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ABBREVIATION LIST 
°C degrees centigrade 
µg microgram 
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µm micrometer 
APMA 
Appr. 
4-aminophenylmercuric acetate 
approximately 
Arg Arginin 
Asp Asprartat 
BC Buffy code 
BSA bovine serum albumin 
CCL chemokine (C-C motif) ligand 
CD cluster of differentiation 
CD14 CD14 positive macrophages 
cDNA complementary deoxyribonucleic acid 
CR complement receptor 
Ct threshold cycle 
CXCL C-X-C motif chemokine ligand 
Cys Cystein 
ddH2O double distilled water 
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DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
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EGF epidermal growth factor 
ELISA enzyme-linked immunosorbent assay 
Fc fragment crystallisable 
g gram / relative centrifugal force 
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
Gly Glycin 
GM-CSF granulocyte-macrophage colony-stimulating factor 
h hour(s) 
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IFNγ interferon gamma 
IgG immunoglobulin G 
IL interleukin 
L liter 
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M molar concentration 
M0 macrophages non stimulated 
M1 classically activated macrophages  
M2 alternatively activated macrophages  
M-CSF macrophage colony-stimulating factor 
met metionin 
min minute(s) 
ml milliliter 
mM millimolar concentration 
mm millimeter 
MMP matrix metalloproteinase 
mRNA messenger RNA 
N equivalent concentration 
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells 
ng nanogram  
nm nanometer 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
Pro Prolin 
pg picogram 
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PMMA polymethylmethacrylate 
pmol picomolar 
RANK receptor activator of nuclear factor kappa B 
RANKL receptor activator of nuclear factor kappa-B ligand 
RNA ribonucleic acid 
RNS reactive nitrogen species 
ROS reactive oxygen species 
rpm revolutions per minute 
RT room temperature 
RT-qPCR reverse transcription real-time polymerase chain reaction 
s second(s) 
Std standard 
TAE tris/Acetate/EDTA-buffer 
TGF transforming growth factor  
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U conventional units 
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1 INTRODUCTION 
1.1 Matrix metalloproteinases 
Matrix metalloproteinases (MMPs) form a class of proteolytic enzymes with a broad 
spectrum of substrates, dedicated to play an essential role in the stabilization of the 
human physiological tissue homeostasis (1, 2). However, in case of deregulated 
expression or activity, they are involved in several pathological processes, such as 
cancer metastasis, chronic inflammation, neurological disorders or the aseptic 
loosening of implants (3, 4). The first MMP was discovered in 1962 as a protease 
capable of degrading fibrillar collagen in tadpole tails during metamorphosis and was 
named interstitial collagenase (5). Step by step more proteases with similar structure 
and function were discovered. They were named according to the substrates they 
can degrade (e.g., gelatinase) or to their presumed function (e.g., matrilysins). Based 
on their similarity in structure and function, the International Union of Biochemistry 
and Molecular Biology organized this class of enzymes as a new family named Matrix 
metalloproteinases (6). This new term indicates the enzyme's capability of degrading 
extracellular matrix as well as its typical structure: containing a Zn²+ ion inside the 
active site (7).  
In over 50 years of MMP research, scientists have been able to achieve several 
important discoveries in this field. A milestone was the identification of "tissue 
inhibitors of matrix metalloproteinases" (TIMPs). TIMPs inhibit MMPs and are 
essential for the balance of its activity and inactivity. Disruption of this tissue 
homeostasis may lead to numerous pathologies (8). Another important discovery was 
MMP’s inactive form (pro-form), which was pioneering for the further understanding 
of MMP’s activity regulation and could direct the attention to mechanisms of MMP 
activation (9). Structural determination of MMPs and the creation of the first MMP 
knockout mouse (MMP-7) complete the significant milestones in MMP research (6). 
Members of the MMP family can degrade almost all components of extracellular 
matrix (ECM) (10), as well as plenty of chemokines, cytokines and growth factors 
(11). This broad spectrum of substrates indicates that MMPs are essential in the 
regulation of physiological and pathological processes (7, 11). 
1.1.1 The classification of matrix metalloproteinases 
Matrix metalloproteinases rank among the metzincin superfamily, that is a clan of 
zinc-dependent endopeptidases, which is complemented by astacins, serralysins, 
pappalysins, adamalysins, snapalysins and leishmanolysins (9, 12). Metzincin are 
characterized by their similar catalytic domains comprising a zinc-binding motif with 
the amino acid sequence HEXXHXXGXX(H/D) as well as a downstream methionine 
containing 1,4 β-turn named "met turn."  
The classification of MMPs in the human genome encompasses 24 different genes 
encoding for 23 MMPs (Table 1). MMP-23 A&B encode two different genes but have 
the same amino acid sequence (13, 14). MMPs were named according to their order 
of discovery. However, some MMPs which were discovered in animals or plants had 
to be excluded as they could not be detected in the human species (MMP-4, -5, -6,-
18,-22) (7). 
The classification of MMP's found in the literature is not consistent and may lead to 
confusion. For instance, the mixture of structural and functional properties as well as 
the mixture of synonyms (e.g., gelatinase A for MMP-2) (9, 15). 
Introduction 
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Basically, MMPs can be categorized into secreted (MMP-1, -2, -3, -7, -8, -9, -10, -11, 
-12, 13,-19, -20, -21, -22, -27, -28) and membrane-anchored proteinases (MMP-14, -
15, -16, -17, 23, 24,-25) (9). Furthermore, a classification according to structural 
properties or functional aspects is possible (Table 1) (13, 15). Regarding their 
structural properties, MMPs are divided into eight groups namely: minimal domain-
MMPs, simple hemopexin-containing domain MMPs, gelatin-binding MMPs, furin-
activated secreted MMPs, vitronectin-like insert MMP, type I transmembrane MMPs, 
glycosylphosphatidylinositol-anchor linked MMPs and type II transmembrane MMPs 
(16). The most conventional classification is based on the MMP substrate specificity 
and their cellular localization (Table 1). It encompasses five subgroups and 
additionally a sixth subgroup of heterogeneous MMPs which does not fit into the 
other groups (9, 11, 16-18) 
 
Table 1. Domain structure and classification of human MMPs 
Modified from Sbardella D, et al. and Visser R, et al. (11, 16-18) 
 
Subgroups MMP- 
number 
Alternative name 
(functional properties) 
Chromosome 
localization 
Structural 
properties 
Collagenases MMP-1 Interstitial collagenase 11q22-q23 simple 
hemopexin-
containing domain 
MMP-8 Neutrophil collagenase 11q21-q22 simple 
hemopexin-
containing domain 
MMP-13 Collagenase-3 11q22.3 simple 
hemopexin-
containing domain 
Gelatinases MMP-2 Gelatinase-A 16q13 gelatin-binding 
MMP-9 Gelatinase-B 20q11.2-q13.1 gelatin-binding 
Stromelysins MMP 3 Stromelysin-1 (transin-1) 11q23 simple 
hemopexin-
containing domain 
MMP-10 Stromelysin-2 11q22.3-q23 simple 
hemopexin-
containing domain 
MMP-11 Stromelysin-3 22q11.2 furin-activated 
secreted 
Matrilysins MMP-7 Matrilysin-1 (Pump-1) 11q21-q22 minimal domain-
MMPs 
MMP-26 Matrilysin-2 
(endometase) 
11p15 minimal domain-
MMPs 
Membrane 
Type MMPs 
 
MMP-14  MT1-MMP 14q11-q12 Transmembrane 
(Typ 1) 
MMP-15 MT2-MMP 15q13-q21 Transmembrane 
(Typ 1) 
MMP-16 MT3-MMP 8q21 Transmembrane 
(Typ 1) 
MMP-24 MT5-MMP 20q11.2 Transmembrane 
(Typ 1) 
MMP-17 MT4-MMP 12q24.3 GPI-anchored 
MMP-25 MT6-MMP 16p13.3 GPI-anchored 
MMP-23 
A+B 
Femalysin 1p36.3 Transmembrane 
(Typ 2) 
Other MMPs MMP-12 Macrophage 11q22.2-q22.3 simple 
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metalloelastase hemopexin-
containing domain 
MMP-19 RASI-1 12q14 simple 
hemopexin-
containing domain 
MMP-28 Epilysin 17q21.1 furin-activated 
secreted 
MMP-20 Enamelysin 11q22.3 simple 
hemopexin-
containing domain 
MMP-21 None 1p 36 vitronectin-like 
insert 
MMP-27 None 11q24 simple 
hemopexin-
containing domain 
 
1.1.2 The structure of matrix metalloproteinases 
All MMPs are synthesized as inactive pre-pro-enzymes and contain three conserved 
structural domains: a signal peptide (pre-domain), a pro-peptide (apart from MMP-23) 
and a catalytic domain with a Zinc²+ ion inside its active site (Figure 1) (13). 
The pre-domain is an N-terminal signal peptide which is cleaved by the signal 
peptidase during entry into the endoplasmic reticulum. This enables the enzyme to 
be either secreted or anchored into the plasma membrane. Intracellular retention of 
the enzyme is possible in case of an inefficient action of the signal sequence (19). 
The pro-peptide is approximately 80 amino acids long and possesses a highly 
conserved sequence (Pro-Arg-Cys-Gly-X-Pro-Asp) located upstream of the catalytic 
domain. The SH-thiol group, part of the cysteine in the pro-peptide, interacts with the 
Zn²+-ion inside the active site, whereby the enzyme is kept in latency. This 
mechanism is called "cysteine switch.” The enzyme is activated and acquires full 
proteolytic capacity when the pro-peptide is removed or disrupted (9, 20). Many 
physiological and pathophysiological pathways of this activation are known. The most 
common is the direct proteolysis by another MMP or protease (7). 
The catalytic domains comprise approximately 165 residues which form together an 
upper and a lower subdomain. The active site is constituted by a zinc-binding 
conserved motif with the sequence HEXXHXXGXXH, where histidine (H), glutamic 
acid (E) and glycine (G) are invariant, and X is a variable residue. The three histidine 
residues coordinate the Zn²+ ion. A methionine contained met-turn follows the active 
site and forms a hydrophobic pillow for the catalytic Zn²+ ion (13). 
Additionally, all MMPs, except MMP-7 and MMP-26, contain a C-terminal hemopexin-
like domain (21). Hemopexin is a scavenger protein and eliminates free toxic haem. 
A number of proteins contain domains which resemble the hemopexin structurally 
and functionally, among them MMPs. They contain four hemopexin-like repeats, 
forming one globular hemopexin domain. This domain fulfills functions in activating 
and inhibiting MMPs, binding and cleavage of substrate, attachment and localization 
of MMPs at the cell surface, endocytosis and degradation of MMPs and 
homodimerization/-multimerization. It is mandatory for the degradation of triple helical 
collagen and plays a decisive role in MMP's substrate specificity (4, 21). The 
absence of the hemopexin domain in MMP-7 and MMP-26 may be one reason for 
their broad substrate specificity (22). 
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Figure 1. The structure of human MMPs. Domain structure of the MMPs. Pre: signal sequence; 
Pro: pro-peptide with a free zinc-ligating thiol (SH) group; F: furin-susceptible site; Zn: zinc-binding 
site; II: collagen-binding fibronectin type II inserts; H: hinge region; TM: transmembrane domain; C: 
cytoplasmic tail; GPI: glycophosphatidylinositol-anchoring domain; C/P: cysteine/proline; IL-1R: 
interleukin-1 receptor. The hemopexin/vitronectin-like domain contains four repeats with the first and 
last linked by a disulfide bond. With permission of Annual reviews nov 1, 2001 copyright 2001 (15).  
 
 
1.1.3 The regulation of matrix metalloproteinases 
MMPs are regulated on different levels of their synthesis including gene expression, 
epigenetic-, post-transcriptional- and activity regulation. The latter encompasses the 
initial zymogene activation as well as their endogenous inhibition (1, 23). Gaffney J et 
al. (2015) (Fig. 2) provide an excellent summary of the complex stepwise regulation 
which is influenced by numerous factors (1).  
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Figure 2. Schematic presentation of multilevel MMP regulation at the level of gene 
expression, zymogen activation and endogenous inhibition. With permission of Elsevier, 
Mai-July 2015, copyright 2015 (1). 
 
 
MMPs are not only regulated by external factors as cytokines hormones and growth 
factors but also cell-cell, and cell-ECM interactions play an essential role in 
transcriptional and post-transcriptional regulation. Due to this fact, their expression is 
specified as a function of cell type and ECM conditions (1, 14). Cell specificity is 
achieved by the restricted expression of transcription factors only by selected cells 
(24). 
Primarily MMPs are regulated at transcriptional level (1, 23, 24), which is a 
reasonable step as the whole process of protein biosynthesis is quite energy 
intensive. Thus an early intervention is more efficient than a later one (25). Fanjul-
Fernández, M et al. (2009) took a closer look at the molecular mechanisms of 
transcription regulation (23). MMP promoters are downstream targets of early 
response signaling pathways. These early response proteins phosphorylate 
transcription factors which are subsequently able to bind promoters of MMP genes 
(23). The transcription factor binding sites inside the promoter are specific for each 
MMP. Due to their frequent repetition in MMP promoters, the PEA3-site, NF-κB-site, 
STAT-site and the AP-1 / -2 site appear to play essential roles in transcription 
regulation. Mainly the AP-1 site is vital as many signal-transduction pathways 
converge at it (14, 23).  
Epigenetic regulation can be performed by DNA-methylation, histone modifying 
enzymes, and chromatin remodeling complexes. Depending on the cell type both 
DNA-methylation and altered chromatin structure can activate or repress MMP gene 
expression. (23, 24) 
Although MMP regulation is mainly performed on the transcriptional level some 
posttranscriptional mechanisms including mRNA stability, post-transcriptional 
efficiency and micro-RNA based mechanisms contribute as well. MMP transcripts 
Introduction 
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possess 5' or 3' untranslated regions (UTRs) where UTR binding proteins can bind 
and either stabilize or destabilize the transcript (23, 26-28).  
The next step in MMP control is the activation of the inactive pro-form via removal of 
the pro-peptide, realized either intracellularly, at the cell surface or within the 
extracellular space (Figure 3) (1). Mechanisms of the activation, listed in Table 2 can 
be discriminated either by their localization or by physiological/non-physiological 
activation.  
 
 
 
Figure 3. Various modes of MMP’s zymogen activation. Intracellular and extracellular 
activation may take place via factors as indicated in the figure. Activation at the cell surface can occur 
by different mechanisms. In the case MMP-2, a complex comprising pro-MMP-2, MT1-MMP, and 
TIMP-2 is formed, enabling the cleavage of pro-MMP-2 by MT-1 MMP and to its activation. With 
permission of Elsevier, Mai-July 2015, copyright 2015 (1) 
 
 
Table 2. Mechanisms of MMP activation. 
Modified from Gaffney J et al. and Cauwe B et al. (1, 7) 
 
The most common physiological mechanism is the proteolysis of the pro-peptide by 
MMPs or other proteases (7). Additionally, oxidation of the thiol group by 
physiological oxidants (e.g., ROS) and disulfides (e.g., RNS), as well as allosteric 
activation via distortion of the catalytic site by binding a receptor or substrate can 
activate MMPs. Alternatively, spliced MMPs which have a lack of the pro-domain can 
be constitutively activated. Non-physiological activation can be attained likewise to 
the physiological ones via distortion of the catalytic site with the distinction that non-
Localization of 
activation 
Mechanisms of activation 
Intracellular Proteolytic (serin/furin proteases, caspases & other MMPs) 
Oxidative stress 
Nitrosative stress 
Phosphorylation 
Alternative splicing 
Cell surface Activation via MT-MMPs 
Extracellular Proteolytic (Serin proteases & other MMPs) 
Thrombin, trypsin, NO, hypoxia, heavy metal ions 
Introduction 
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physiological reagents such as organomercurials (APMA), chaotropic agents (urea), 
and detergents (e.g., SDS) activate MMPs. Additionally, alkylating agents and heavy 
metal ions can activate MMPs via modification of the cysteine in the pro-domain (7). 
In order to ensure that MMP activity is neither too high nor too low, it is crucial to 
guarantee tight control. Otherwise, an impaired MMP activity can lead to irregular 
ECM turnover and numerous diseases (Table 5) (8). This control is mainly achieved 
by the tissue inhibitors of metalloproteinases (TIMPs) via blocking the enzyme's 
active site with a conserved anchor in a tight 1:1 complex (29). Thus, the balance 
between TIMPs and MMPs is decisive whether MMPs are active or not. However, 
also other factors such as α2-macroglobulin are capable of inhibiting MMPs (30, 31). 
Generally, all TIMPs have the capability of inhibiting all known MMPs, although their 
efficacy varies for each MMP (30). The opinion that a shift of the balance between 
MMPs and TIMPs in favor of TIMPs leads to fibrosis and vice versa to proteolysis is 
no longer generally accepted (30). Since it is known that MMPs function goes far 
beyond degrading just ECM and that it plays an essential role in activating or 
inactivating many biologically active proteins, it is suggested that MMPs can do both: 
directly inhibit ECM proteolysis and indirectly control ECM turnover (30). For 
instance, the growth factor TGFβ leads to increased deposition of ECM (32) and is 
activated directly by MMP-2, -9 and -13 (33, 34) as well as indirectly by MMP-7 (35). 
This implies that inhibition of MMPs via TIMPs indirectly decreases the TGFβ 
mediated ECM deposition and results in ECM degradation (30). As only some MMPs 
activate TGFβ, it has to be noted that the specific role of each TIMP is dependent on 
the MMP it is inhibiting. Given that the surrounding ECM influences expression and 
activity of MMPs their function is also dependent on the local tissue environment (30). 
 
1.1.4 Functions of human matrix metalloproteinases 
Initially, MMPs were identified as enzymes with crucial functions for the degradation 
of ECM, but more recently a growing number of non-ECM substrates including 
chemokines, cytokines, and growth factors have been identified (Table 3). MMPs do 
not only degrade these substrates; they can also activate them, which enables MMPs 
to contribute to many physiological and pathological processes. They play a vital role 
in inflammation as they recruit inflammatory cells or regulate their transmigration from 
vasculature to the site of inflammation in tissue. This recruitment and transmigration 
is achieved by cleavage of ECM and non-ECM substrates as well as the creation of 
chemokine gradients (chemotaxis) (11). They are also involved in tissue remodeling 
processes such as embryonic development, tissue morphogenesis, skeletal growth 
and wound repair (7, 11, 16). 
However, MMPs and their function of cleaving ECM and non-ECM substrates have 
been attributed to numerous pathologies including tumor metastasis, arthritis, 
glomerulonephritis, periodontal disease, tissue ulcerations, cardiovascular disease, 
neurodegenerative diseases and peri-implant loosening (36, 37). MMP inhibition as a 
therapeutic approach was tried in the last years, but with little clinical success. One 
reason may be that the spectrum of the function of each MMP is still not understood 
completely. Therefore further studies are limited, as beneficial functions should not 
be modulated (36, 38). A complementation of the MMP’s substrate spectrum is 
crucial in order to understand pathologies in which MMPs are involved. 
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Table 3. Macromolecular substrates of MMPs 
Modified from Nissinen L et al. and Sbardella D et al. (11, 16). 
 
Subgroup MMP-
number 
ECM substrates Non ECM substrates 
Collagenases MMP-1 Collagens I, II, III, VII,VIII, 
X; gelatin; aggrecan; link 
protein; entactin; 
tenascin; perlecan 
α2-M; α-PI; α1-antichymotrypsin; 
IGFBP-2, 3, 5; proIL-1β; CTGF; α1-
antitrypsin/α1-antichymotrypsin; IL-
1β; Latent TNF-α; MCP-1, -2, -3, -
4; SDF-1; VEGF 
 
MMP-8 Collagens I, II, III, V, VII, 
VIII, X; Fn; entactin; 
tenascin; 
gelatin; aggrecan; link 
protein 
 α1-antitrypsin; CXCL5; IL-8 
MMP-13 Collagens I, II, III, IV, VII, 
IX, X, XIV; aggrecan; 
gelatin; Fn; 
tenascin; osteonectin; Ln; 
perlecan 
CTGF; ProTGF-β; MCP-3; α1- 
antichymotrypsin; plasminogen; 
Latent TNF-α; SDF-1  
 
Gelatinases 
 
MMP-2 Gelatin; collagens I, IV, 
V, VII, X, XI, XIV; Ln; Fn; 
elastin; aggrecan; 
osteonectin; link protein 
ProTGF-β; FGF receptor I; MCP-3; 
IGFBP-5; 
proIL-1β; galectin-3; plasminogen 
IL-1β; SDF-1; MCP-3; IGFBP-3; 
Latent TNF-α;  Pleiotrophin; CTGF; 
Decorin (35) 
 
MMP-9 Gelatin; collagens I, III, 
IV, V, VII, X, XII; elastin; 
entactin; 
aggrecan; Fn; link 
protein; vitronectin; N-
telopeptide of 
collagen I 
ProTGF-β; IL-2 receptor a; Kit-L; 
IGFBP-3; 
proIL-1β; ICAM-1; α1-PI; galectin-
3; plasminogen; α1-antitrypsin; IL-
1β; CXCL5; IL-8; SDF-1; Latent 
TGF-β; Latent TNF-α; IL-2Rα; 
IGFBP-1; VEGF 
Stromelysins MMP-3 Aggrecan; decorin; 
gelatin; Fn; Ln; collagens 
III, IV, V, IX, 
X, XI; tenascin; link 
protein; perlecan; 
osteonectin; 
entactin 
IGFBP-3; proIL-1β; HB-EGF; 
CTGF; Ecadherin; 
α1-antichymotrypsin; α1-PI; α2- 
M; plasminogen; uPA; pro-MMP-1, 
7, 8, 9, 13 
α1-antitrypsin/α1-antichymotrypsin; 
IL-1β; Pro-IL-1β; MCP-1, -2, -3,-4; 
SDF-1; IGFBP-1, 3; Latent TGF-β; 
Pro-HB-EGF; Latent TNF-α; TNF-
α; Osteopontin; VEGF; Decorin(35) 
 
MMP-10 Aggrecan; Ln; Fn; 
gelatin; collagens III, IV, 
V, IX, X, XI; 
tenascin; link protein; 
Pro-1, 8, 10 
MMP-11 Fn; Ln; aggrecan; 
gelatins 
α1-antitrypsin; α2-M; IGFBP-1  
Matrilysins MMP-7 Aggrecan; gelatin; 
Fn(39); Ln; elastin; 
entactin; collagens, III, 
IV(39), V, IX, X, XI; 
Proα-defensin; b4 integrin; E-
cadherin; 
CTGF; HB-EGF; RANKL; 
IGFBP-3; plasminogen; α1-
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tenascin; Decorin (35); 
link protein; 
Vitronectin; 
antitrypsin; Pro-HB-EGF; Latent 
TNFα; Syndecan-1; Osteopontin; 
CellularmembraneboundFasL; 
VEGF; NGF (20); 
 
MMP-26 Gelatin; collagen IV; Fn; 
fibrinogen; vitronectin 
pro-MMP-9; α1-antitrypsin 
Membran 
Type MMPs 
MMP-14  Collagen I, II, III; gelatin; 
aggrecan; Fn; Ln; fibrin; 
vitronectin; entactin; 
proteoglycans; Ln-5 
Pro-MMP-2; Pro-MMP-13; CD44; 
MCP-3; 
tissue transglutaminase; SDF-1 
MMP-15 Fn; tenascin; nidogen; 
aggrecan; entactin; 
collagen; 
gelatin; perlecan; Ln; 
vitronectin 
Pro-MMP-2; tissue 
transglutaminase 
MMP-16 Collagen III; aggrecan; 
gelatin; Fn; vitronectin. 
Pro-MMP-2; tissue 
transglutaminase; VEGF 
MMP-24 Gelatin;fibronectin; 
vitronectin; collagen, 
aggrecan; PG 
Pro-MMP-2 
 
MMP-17 
Gelatin; fibrinogen TNFα 
MMP-25 Gelatin; collagen IV; 
fibrin; Fn; Ln 
ProMMP-2 
MMP-23 Gelatin unkown 
Other MMPs MMP-12 Elastin; aggrecan; Fn; 
collagen IV; gelatin; 
vitronectin; 
entactin; osteonectin; Ln; 
nidogen 
Plasminogen; apoliprotein(a); 
Latent TNF-α 
MMP-19 Collagen IV; gelatin; Fn; 
tenascin; aggrecan; 
enatctin; 
COMP; Ln; nidogen 
IGFBP-3; proIL-1β; HB-EGF; 
CTGF; Ecadherin; 
α1-antichymotrypsin; α1-PI; α2- 
M; plasminogen; uPA; pro-MMP-1, 
7, 8, 9, 13; VEGF 
MMP-28 unkown Casein 
MMP-21 unkown unkown 
MMP-20 Amelogenin; aggrecan; 
gelatin; COMP 
unkown 
MMP-27 unkown unkown 
 
 
1.1.5 Cell and disease specific expression of matrix metalloproteinases 
In order to understand pathologies in which MMPs are involved, it is essential to 
identify the cell types which express MMPs. MMPs are expressed most frequently in 
macrophages, endothelial cells, fibroblasts and adipocytes, although various other 
cells also produce MMPs (Table 4). Macrophages are key innate immune cells 
playing a decisive role in homeostasis as well as in inflammatory and healing 
processes. Effects of macrophages on their local tissue environment include trophic, 
homeostatic and defense functions, cytocidal interactions with neighboring cells, 
phagocytosis and remodeling of extracellular matrix (2). The latter is mainly attributed 
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to the matrix metalloproteinases secreted mostly by macrophages. Macrophages 
express twenty out of 23 human MMPs. Only for MMP-20, MMP-23, and MMP-24, 
there is no expression by macrophages reported in the literature (Table 4).  
 
Table 4. The Expression of MMPs in different cell types under healthy and pathological 
conditions. Modified from Iyer RP et al. (6) 
MMP type Expressing cell type 
MMP-1 endothelial cells, fibroblasts, macrophages, smooth muscle cells 
(40), cardiac fibroblasts (41), alveolar macrophages (42), adipocytes 
(43) 
MMP-2 endothelial cells, fibroblasts, platelets, T-lymphocytes, smooth 
muscle  cells (40), adipocytes (40), cardiac fibroblasts (41), 
macrophages (44) 
MMP-3 endothelial, fibroblasts, macrophages, smooth muscle (40), 
adipocytes (43) 
MMP-7 macrophages, gastric epithelial cells (45), mesangial cells(32), lung 
adenocarcinoma cells (46), pancreatic ductal adenocarcinoma cells 
(47), epithelial cells (22) 
MMP-8 neutrophils, endothelial cells, fibroblasts, macrophages(5) 
MMP-9 neutrophils, endothelial cells, eosinophils, macrophages(48), T 
lymphocytes, adipocytes (40, 43) cardiac fibroblasts (41) 
MMP-10 fibroblasts, T lymphocytes, macrophages (49), adipocytes (43) 
MMP-11 fibroblasts, macrophages (50) 
MMP-12 macrophages, stromal-cells, adipocytes (43) 
MMP-13 fibroblasts, macrophages (51) 
MMP-14 fibroblasts, macrophages 
MMP-15  fibroblasts, macrophages 
MMP-16  fibroblasts, macrophages, vascular smooth muscle cells 
MMP-17 eosinophils, lymphocytes, monocytes, macrophages (52) 
MMP-19 vascular smooth muscle cells, endothelial cells, monocytes, 
adipocytes (43) 
MMP-20 endothelial cells 
MMP-21 fibroblasts(53), macrophages(53) 
MMP-23 Unknown 
MMP-24 Unknown 
MMP-25 neutrophils, monocytes 
MMP-26 B-lymphocytes, macrophages (53) 
MMP-27 fibroblasts, macrophages (54) 
MMP-28 cardiomyocytes, macrophages, T-lymphocytes 
 
 
Table 5 gives an overview of the involvement of MMPs in different pathologies. 
Collagenases (MMP-1, -8, -13) have been attributed to atherosclerosis, heart failure 
and aortic aneurysm. However, it seems that their role in tumorigenesis is of minor 
relevance. Gelatinases (MMP-2, -9) are mainly connected to inflammatory processes, 
autoimmune diseases, and neoplastic pathologies. Likewise, stromelysins (MMP-3, -
10, -11) and the matrilysin MMP-7 were described to play a significant role in tumor 
diseases. Additionally, cardiovascular, neuronal and respiratory diseases are 
attributed to MMP-7. Diseases with the involvement of membrane-type-MMPs (MMP 
14, -15, -16, -17, -24, -25) encompass neoplastic diseases, but they have also been 
described in cardiovascular, respiratory, nervous, and rheumatic diseases. The role 
of MMPs in specific tumor entities is not discussed as it would exceed the extent of 
this thesis (16). 
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The previously shown abundant spectrum of substrates of MMPs (Table 3), their 
nearly complete presentation in macrophages and the connection to pathologies 
(Table 5), gives reasons for further examinations of these enzymes in macrophages.  
 
 
Table 5. Involvement of MMPs in different pathologies. 
Modified from Sbardella D et al. (16). 
System Disease MMP 
Cardiovascular Aortic aneurysm MMP-1 MMP-2 (55) MMP-3 MMP-
7 MMP-8 MMP-9 MMP-12 MMP-
13 MMP-14 
Atherosclerosis MMP-1 (56) MMP-2 MMP-3(56) 
MMP-8 MMP-9 MMP-10 MMP-11 
MMP-12(56) MMP-13 MMP-14 
Myocardial infarction MMP-2(57) MMP-3 MMP-7 MMP-9 
(57) MMP-13 MMP-14 
Left ventricular hypertrophy MMP-1 MMP-7 MMP-13 MMP-14 
Stroke MMP-2 MMP-3 MMP-9 MMP-12 
MMP-13 MMP-14 
Nervous Alzheimer MMP-1 MMP-2 MMP-9 MMP-24 
Blood–brain barrier (BBB) 
disruption 
MMP-2 MMP-7 MMP-9 MMP-14 
Brain injury MMP-7 MMP-13 
Encephalomyelitis MMP-8 MMP-9 MMP-12 MMP-25 
HIV-dementia MMP-7 
Intracerebralhemorrhage (ICH) MMP-12 
Meningitis MMP-8 MMP-12 
Multiple sclerosis MMP-2 MMP-7 MMP-9 MMP-12 
MMP-19 MMP-25 
Parkinson MMP-3 
Spinal cord injury MMP-12 
Vascular dementia MMP-1 
Joint and 
muscular 
Dupuytren MMP-7 
Inflammatory myopathies MMP-7 
Medial collateral ligament (MCL) 
injury 
MMP-12 
Osteoarthritis (OA) MMP-1 MMP-2 MMP-3 MMP-7 
MMP-8 MMP-9 MMP-13 MMP-14 
MMP-16 
MMP-17 
Polymyositis MMP-9 
Rheumatoid arthritis (RA) MMP-1 MMP-2 MMP-3 MMP-8 
MMP-9 MMP-12 MMP-13 MMP-14 
MMP-19 
Respiratory Acute respiratory distress syndrome 
(ARDS) 
MMP-3 
Asthma MMP-1 MMP-8 MMP-9 MMP-12 
MMP-25 
Emphysema/chronic obstructive 
pulmonary disease. (COPD) 
MMP-1 MMP-8 MMP-9(58) MMP-
12 MMP-14 MMP-25 
Idiopathic pulmonary fibrosis (IPF) MMP-1 MMP-7 MMP-12 
Lung fibrosis MMP-1 MMP-7 MMP-8 MMP-12 
Digestive Liver fibrosis MMP-1 MMP-8 MMP-12 MMP-13 
MMP-15 
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Liver cirrhosis MMP-8 MMP-9 
Infectious 
diseases 
Helicobacter pylori MMP-1 
Mycobacterium tuberculosis MMP-1 MMP-7 
Schistosomiasis MMP-12 
Autoimmune 
diseases 
Autoimmune inner ear MMP-9 
Bullosuspemphigoid MMP-9 
C-protein induced myocarditis MMP-9 
Lupus erythematosus MMP-2 MMP-9, MMP-3(59) 
Sjögren Syndrome MMP-9 
Other diseases Diabetic nephropathy MMP-24 MMP-7(32) 
Endometriosis MMP-1 MMP-2 MMP-3 MMP-7 
MMP-13 MMP-24 
Periodontal inflammation MMP-2 MMP-8 MMP-9 MMP-13 
MMP-25 
Wound healing  MMP-1 MMP-2 MMP-3 MMP-8 
MMP-9 MMP-10 MMP-11 MMP-13 
MMP-14 
MMP-28 
 
1.1.6 Matrix metalloproteinases in implantation 
MMPs play a decisive role in ECM remodeling and destruction as they are capable of 
degrading almost all parts of the extracellular matrix (3, 10). The role of ECM 
remodeling is of particular interest in medical fields where implants are used 
frequently, for instance in the orthopedic field and odontology. A main complication in 
implantology is aseptic implant loosening, which has been associated with multiple 
factors as micromotion of the implant, hydrostatic fluid pressure or wear-generated 
particular debris. The latter is attributed to be the primary factor (3). Wear debris 
includes various components of the implant and is phagocytized by macrophages. 
This activates them and leads to secretion of multiple cytokines as well as MMPs 
contributing to periprosthetic osteolysis (3, 60). Evidence in support of the essential 
role of this pathology includes the fact that more than 70% of hip revisions and more 
than 44% of knee revisions are caused by aseptic implant loosening (61, 62). 
Several studies showed that MMPs are induced by different implant material ranging 
from hip prosthesis and dental implants to experimentally generated wear debris. The 
cell spectrum expressing MMPs represents not only macrophages, although they 
represent a primary source of the enzyme (Table 6). 
 
 
Table 6. Involvement of MMPs in implantation. Arrow up (↑) = induction of MMP by 
implant; arrow straight (→) = no effect on MMP expression by implant 
 
MMP Implant type/material Effect on 
MMPs 
Cells /tissue 
involved 
Refere
nces 
MMP-1 • hip prosthesis 
 
 
• wear debris 
(including also 
titanium) 
↑ 
 
 
↑ 
• periprosthetic 
tissue of loose 
artificial hip joints 
• osteoblasts 
(63, 64) 
 
 
(65) 
MMP-2 • Titanium alloy 
particels (implant 
↑ 
 
 
• Peripheral 
monocytes 
(66) 
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tissue) 
• polymethylmethacryl
ate (PMMA) 
• hip prosthesis 
 
 
• dental implants (not 
indicated which material) 
↑ 
 
→ 
 
 
→ 
 
• Peripheral 
monocytes 
• periprosthetic 
tissue of loose 
artificial hip joints 
• salivary 
(66) 
 
(64) 
 
 
(67) 
MMP-3 • wear debris 
(including also 
titanium) 
 
↑ • macrophages (65) 
MMP-7 • Titanium alloy 
particles (implant 
tissue) 
• polymethylmethacryl
ate (PMMA) 
• hip prosthesis 
↑ 
 
 
↑ 
 
→ 
• Peripheral 
monocytes 
• Peripheral 
monocytes 
• periprosthetic 
tissue of loose 
artificial hip joints 
(66) 
 
(66) 
 
(64) 
 
MMP-8 • hip prosthesis 
 
 
• dental implant 
 
• wear debris 
(including also 
titanium) 
• wear debris 
(including also 
titanium) 
→ 
 
 
↑ 
 
↑ 
 
 
↑ 
• periprosthetic 
tissue of loose 
artificial hip joints 
• Peri-implant-
sulcus fluid 
• macrophages 
 
 
• osteoblasts 
(64) 
 
 
(28) 
 
(65) 
 
 
(65) 
MMP-9 
 
• Titanium alloy 
particles (implant 
tissue) 
• Polymethylmethacryl
ate (PMMA) 
• hip prosthesis 
 
• Titanium 
↑ 
 
 
↑ 
 
↑ 
 
↑ 
• Peripheral 
monocytes 
• Peripheral 
monocytes 
• periprosthetic 
tissue of loose 
artificial hip joints 
• osteoclasts 
(66) 
 
(66) 
 
(64) 
 
 
(68) 
MMP-10 
 
• hip prosthesis 
 
 
• wear debris 
(including also 
titanium) 
↑ 
 
 
↑ 
• periprosthetic 
tissue of loose 
artificial hip joints 
• macrophages 
(64) 
 
 
(65) 
MMP-11 • hip prosthesis → • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
MMP-12 • hip prosthesis 
 
↑ • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
MMP-13 • hip prosthesis 
 
↑ • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
MMP-14 • hip prosthesis → • periprosthetic 
tissue of loose 
(64) 
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artificial hip joints 
MMP-15 • hip prosthesis → • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
MMP-16 • hip prosthesis → • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
MMP-17 • hip prosthesis → • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
MMP-19 • hip prosthesis → • periprosthetic 
tissue of loose 
artificial hip joints 
(64) 
 
 
 
1.1.7 Specific functions of matrix metalloproteinase 7 
As previously described, MMP-7 has a lack of hemopexin domain which is 
responsible for the enzyme's substrate specificity. Due to the absence of the 
hemopexin domain, MMP-7 has one of the broadest substrate spectrums among the 
family of MMPs and can degrade most proteins of the extracellular matrix (22). Such 
broad substrate specificity is essential for the migration of epithelial cells in 
embryogenesis and wound repair but on the other hand detrimental for pathological 
processes like tumor metastasis (69, 70), or the loosening of an implanted prosthesis 
(19). Functions of MMP-7 are not only attributed to the degradation of extracellular 
matrix; it regulates cell migration, tissue repair and plays a vital role in the 
maintenance of innate immunity (22) (Table 3). Zhang Zhi et al. could demonstrate 
that MMP-7 inactivates human α1-antitrypsin by cleavage, which was accompanied 
by a corresponding loss of its inhibitory capacity towards neutrophil elastase (71). 
The up-regulated activity of neutrophil elastase can enhance inflammation by the 
activation of IL1-b and IL-18 (72). MMP-7 activates Pro HB-EGF to its active form 
(34), which has been shown to contribute to cell proliferation and migration, wound 
healing as well as to cell survival (35, 73, 74). Hirotako Haro et al. developed a 
murine organ culture model with intervertebral disks. They could show that 
macrophage secreted MMP-7 activated soluble TNFa, which induced MMP-3 in 
chondrocytes. MMP-3 released a macrophage chemoattractant which resulted in 
macrophage infiltration into the disks as well as proteoglycan loss and disk resorption 
(75). Furthermore, in another mouse model, it has been demonstrated that MMP-7 
cleaves Syndecan-1 which releases the chemokine CXCL-1, bound with Syndecan-1 
in a complex. The shed complex can create a chemotactic gradient, guiding 
neutrophils into the alveolar space (76). 
  
 
Table 7. Role of MMP-7 specfic activites in immune responses. 
MMP Model Substrate Response Consequence Reference 
MMP-7 Human 
enzymes 
α1-
antitrypsin 
Inactivation Enhanced activity of 
neutrophil elastase 
(77) 
mouse Pro HB-EGF Activation Cell survival, 
proliferation, 
migration, wound 
healing 
(34) 
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mouse Latent TNF-α Activation macrophage tissue 
infiltration (disks). 
enhanced disk 
resorption 
(75) 
mouse Syndecan 1 Activation 
(shedding) 
Creating together with 
chemokine a 
chemotactic gradient 
for neutrophils 
(78) 
 
 
1.2 The monocyte/macrophage based model system for the analysis of 
macrophage response to titanium surfaces established in our laboratory. 
Foreign body reaction to biomaterials is an immunologically and inflammatory-driven 
process in which macrophages play a central role. The paradigm of M1 and M2 
macrophages is useful in order to distinguish pro-inflammatory M1 macrophages 
from anti-inflammatory and pro-fibrotic M2 macrophages. If the foreign body 
equilibrium is disturbed, macrophages are activated that may lead to a process of 
bone resorption resulting in the implant failure (79). Otherwise, the profibrotic 
functions of M2 macrophages, leading to a restricted range of motion, may result in 
implant failure as well (80). 
Resident tissue macrophages are partially derived from circulating monocytes in the 
bloodstream. Their differentiation and activation in tissue is influenced by cytokines, 
growth factors, hormones and implant material (65). In order to understand the 
response of macrophages to implant material or other challenges, a model system 
based on the cultivation of M1 and M2 macrophages, challenged with different 
stimuli, was established by our laboratory. 
A two-step gradient centrifugation was used to isolate human monocytes from buffy 
coats, which are the best source of functionally active monocytes. In the first step 
biocoll separating solution was used to isolate peripheral blood monocytes, and in 
the second step, the separation was performed with percoll, in order to enrich the 
cells. CD14+ cells were selected and cultured with serum medium, supplemented 
with 5 mmol/l glucose, 5ng/ml of M-CSF and 10-8 mol/l dexamethasone. For 6 days, 
the cells were incubated either on plastic or titanium disks as well as stimulated with 
different cytokines, in order to differentiate them in different types of macrophages. 
The cells were stimulated with interferon gamma (IFNγ), differentiating the 
monocytes into pro-inflammatory M1 macrophages or with Interleukin 4 (IL4), 
generating anti-inflammatory M2 macrophages. A third group obtained no stimulation 
(M0 macrophages). Cells were harvested on day 1, 3 and 6 of incubation to analyze 
molecular biomarkers (81). 
In order to analyze the effect of titanium on the gene expression in macrophages, a 
microarray gene expression analysis was performed by Dr. Alexandru Gudima 
(realization of experiments) and Dr. Carsten Sticht (statistical analysis) in our 
laboratory. For microarray analysis, cells were harvested on day 6 of incubation and 
used for RNA isolation. 6 out of 8 donors based on integrity, number and RNA 
concentration were chosen for microarray analysis. For each donor, 6 different 
groups of macrophages were analyzed: M(Control), M(IFNγ), M(IL-4), M(Control) Ti, 
M(IFNγ) Ti, and M(IL-4) Ti (82). 
Microarray analysis provided a list of genes whose expression changed in response 
to titanium disks. A cut off corresponding to a 2-fold change in gene expression was 
introduced in order to get more biologically meaningful results (in contrast to only 
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statistically significant). MMP-7 was one of the genes which were most up-regulated 
in macrophages cultured on porous titanium disks vs. control (82). Additionally, MMP-
7’s broad substrate spectrum, indicating for high biological relevance (21), and the 
fact that an up-regulation of MMP-7 in tissue next to titanium implants was also 
identified by others (83), made it to the first choice for validation in further 
experiments (RT-PCR, ELISA and analysis of active MMP7). 
 
1.3 Aims and objectives of the study. 
Titanium is a frequently used implant material applied in many different medical 
fields, such as orthopedics or oral implantology. Currently, the predominant 
complication in the sector of joint replacement is the aseptic loosening of 
endoprosthesis. The degradation of extracellular matrix by MMPs has been 
considered to be a main factor in the process of aseptic loosening.  
The aim of this work was to examine the effect of human primary macrophage 
exposure to titanium on the MMP-7 production. 
 
The specific objectives were: 
 
• Identification of titanium induced changes in gene expression and secretion of 
MMP-7 in human primary M0, M1 and M2 macrophages. 
 
• Analysis of titanium induced MMP-7 on three different levels of MMP-7 regulation 
(mRNA, Protein, activity). 
 
• Analysis of TIMP-3 and CD151, regulators of MMP-7 activity, in response to 
titanium stimulation in human primary M0, M1 and M2 macrophages. 
 
• Analysis of differential effects of porous and polished titanium on MMP-7 
production by M0, M1, and M2 macrophages. 
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2 MATERIALS AND METHODS 
This work was written using the operating system Windows 7 and the word processor 
Microsoft Office Word 2007. Graphical representations were made using Microsoft 
Office Excel 2007, GIMP 2.8 and GraphPad Prism 6. 
All experiments, except the experiments with polished titanium, were performed with 
monocyte-derived macrophages of the same donors. 
2.1 Chemicals, reagents and kits 
Table 8. Chemicals, reagents and kits 
Product Company 
Incomplete PCR buffer 10x BIORON 
Tris-Acetate EDTA (TAE) buffer 50x Eppendorf 
Agarose Roth 
Bovine Serum Albumin (BSA)  Sigma 
Deoxyribonucleotides (dNTPs) 10M Fermentas 
DEPC Water Thermo Scientific 
Dimethylsulfoxide (DMSO) Sigma 
GeneRuler DNA ladder Fermentas 
Loadingdye 6x Fermentas 
MgCl2 Sigma 
GelRed Nucleic Acid Gel stain Biotium 
Oligo(dt) primer Thermo Scientific 
PBS Dulbecco, w/o Ca 2+, Mg 2+ Biochrom AG 
PCR primers (designed in the lab) Eurofinsn MWG Operon 
PCR probes (designed in the lab) Eurofins MWG Operon 
Phosphate buffered saline (D-PBS), sterile 1x Invitrogen 
Sensimix II probe kit Bioline 
Taqpolymerase 5 u/µl BIORON 
Tween 20 Sigma 
 
2.2 Consumables 
Table 9. Consumables 
Product Company 
Parafilm American National Can 
PCR tubes Star Labs 
Pipette tips Eppendorf 
Pipettes Gilson, Eppendorf 
Safe-Lock Eppendorf Tubes, 1.5ml Eppendorf 
Sterile pipettetips Avantguard, Star Labs, Nerbeplus 
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Tubes Falcon 
 
2.3 Equipment 
Table 10. Equipment used in the study. 
Product Company 
Agarose electrophoresis unit i-Mupid Erogentec 
Centrifuge 5415 R Eppendorf 
Centrifuge Rotina 420 Hettich 
Centrifuge Rotina 420R Hettich 
Cryofreezingcontainer Nalgene 
Deepfreezer (-80°C) Sanyo 
Electrophoresiscomb Peqlab 
Electrophoresis power supply Peqlab 
Elisa plate sealers R&D systems 
Elisa Plates R&D systems 
Freezer (-20°C) Liebherr 
Icemachine Scotsman AF100 
Incubator 37°C Edmund Bühler GmbH 
Magneticstirrer MR3000 Heidolph 
Microwave oven Sharp 
Scalpel Feather 
Shaker KS 260 basic IKA 
Tecan Infinite M200 Tecan 
Thermocycler DNA Engine PTC220 Dyad MJ Research 
Thermomixer 5436 Eppendorf 
Benchtop UV Transilluminator UVP 
Vortex Genie 2 Scientific Industries 
Water bath Memmert 
 
2.4 Kits 
Table 11. Kits 
Product Company 
RevertAid H Minus First Strand Synthesis 
Kit 
Fermentas 
Human total MMP-7 quantikine ELISA kit R&D systems 
Human MMP-7 activity assay Quickzyme 
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2.5 Buffers and solutions 
50xTAE buffer  
242g of Tris free base and 18.61g of Disodium EDTA were added to 700ml 
ddH2O and stirred until they dissolved. 57.1ml Glacial Acetic Acid was added 
and the volume was adjusted to 1L. 
1xTAE buffer 
20ml of 50xTAE buffer was added to 980ml of ddH2O. 
Wash buffer for ELISA (0.05% Tween 20 in PBS) 
500µl of Tween 20 was pipetted into 1L of PBS. The beaker was stirred on a 
magnetic stirrer for 30min and the solution was stored at RT. 
 
2.6 Nucleic acid related methods 
2.6.1 Polymerase chain reaction (PCR) 
PCR was performed in order to test the quality of the cDNA and the quality of the 
primers before proceeding to real time PCR optimization. 
DNA fragments from cDNA were amplified using primers specific to the gene of 
interest. 
 
1. All of the following reagents, minus the polymerase and cDNA template, were 
added to an Eppendorf tube to make a master mix for the number of samples 
and mixed by vortexing: 
 
Table 12. Reagents for PCR 
Reagent Amount 
(µL) 
Buffer (w/o +Mg2+) 10x 2.5 
MgCl2 (100 mM) 0.4  
dNTPs (10 mM) 0.5  
Forward primer (10 pmol/µL) 1  
Reverse primer (10 pmol/µL) 1  
Taq polymerase (5 U/µL) 0.3   
cDNAtemplate 1  
ddH2O 18.3 
 
2. The polymerase was added, and the solution was mixed by pipetting. 
3. The master mix was divided amongst PCR tubes containing the template 
samples and mixed by pipetting. 
4. The tubes were placed in a thermocycler and the following program was used 
for amplification of the target gene: 
 
Table 13. PCR protocol 
95°C 10 min 
95°C 15 sec 
60°C 1min 
4°C ∞ 
35x 
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*PCR products were visualized using agarose gel electrophoresis. 
 
2.6.2 Agarose gel electrophoresis 
1. Agarose solution was prepared with agarose powder and electrophoresis 
buffer (1x TAE). The percentage of agarose was selected according to the 
size of the DNA fragments: 
 
 
Table 14. Size ranges for Agarose gel 
% Agarose DNA size (bp) 
0.5 1,000-30,000 
0.7 800-12,000 
1.0 500-10,000 
1.2 400-7,000 
1.5 200-3,000 
2.0 50-2,000 
 
2. GelRed 0,01% nucleic acid gel stain was added to the agarose solution and 
mixed. 
3. The solution was cooled down to 55-60°C with magnetic stirring and poured 
into the gel tray with comb. 
4. The comb was removed carefully when the solution was solidified. 
5. Gel tray was placed in the electrophoresis unit and filled with 1x TAE buffer. 
6. 2μL of loading dye was added to 2µL of the PCR product and to 8µL of 
ddH2O.The samples were loaded onto the gel. 
7. 3μL of GeneRuler DNA Ladder was added to the first lane to verify the size of 
the target fragments. 
8. Electrophoresis was carried out at constant voltage (130 V) for 50 min. The 
results were visualized by UV illumination (254 nm) and documented using a 
gel documentation system. 
2.6.3 cDNA synthesis 
cDNA synthesis was performed using RevertAid H Minus First Strand Synthesis Kit 
from Fermentas. Prior to cDNA synthesis all RNA samples were digested with 
DNAse I to remove possible contamination of genomic DNA. 
 
DNA digestion: 
 
1. DNase was digested by mixing the following in an RNase-free Eppendorf tube: 
 
Reagent Amount (µl) 
Total RNA 5  
DNase buffer with MgCl2 10X 1 
RNAse free DNase I  1 
Distilled water (RNase free)  3 
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2. Digestion was performed at 37°C for 40 min in a thermoblock followed by enzyme 
inactivation at 70°C for 10 min. 
3. The samples were put on ice 
 
cDNA synthesis: 
 
1. 1 µl of Oligo dT primer and 1µl of distilled RNase free water were added to DNase 
I   digested RNA samples. 
2. Samples were incubated at 70°C for 5 min in order to perform primer annealing. 
3. Subsequently the following components were added to the samples and mixed 
well: 
 
Reagent Amount (µl) 
5X reaction buffer for polymerase 4 
Ribolock RNase inhibitor   1 
dNTP mix (10mM)  2 
RevertAid H minus reverse transcriptase 1 
 
4. Reaction was incubated at 42°C for 1h at a thermoblock. 
5. The enzymatic activity was stopped by additional incubation at 70°C for 10 min. 
6. cDNA samples were diluted 10 times with ddH2O. 
7. The cDNA synthesis efficiency was checked by amplifiying the house-keeping 
gene GAPDH using PCR and gel electrophoreses as described above. 
2.6.4 Real time PCR with Taqman probe 
All primers and dual-labeled probes were ordered from Eurofins Genomics. Dual-
labeled probes contained FAM on 5’ end and BHQ1 quencher at 3’ end of sequence. 
Primers were optimized by pipetting them with the following schema (Table 15). 
 
Table 15. Pipetting schema for primer optimization 
F: Forward Primer; R: Reverse Primer; 
 
F50nM 
R50nM 
F50nM 
R300nM 
F50nM 
R600nM 
F300nM 
R50nM 
F300nM 
R300nM 
F300nM 
R600nM 
F600nM 
R50nM 
F600nM 
R300nM 
F600nM 
R600nM 
 
The primer combination with the earliest and steepest curve was chosen for 
optimization of the probe which was pipetted in concentrations between 50nM-250nM 
with the optimized primers. The probe with the earliest and steepest curve was 
chosen. 
The following primers and probe were used for further RT-PCR analysis (Table 16) 
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Table 16. Primers and probe for real-time PCR designed in our lab. All primers and probes 
were ordered from Eurofins MWG Operon. 
Gene Type Sequence (5' to 3') Concentration 
MMP7 Forward CTTCCTGTATGCTGCAACTCA 900nM 
Reverse GGGATCTCCATTTCCATAGG 900nM 
Probe TCCCATACCCAAAGAATGGCCAA 150nM 
GAPDH Forward CATCCATGACAACTTTGGTATCGT 900nM 
Reverse CAGTCTTCTGGGTGGCAGTGA 300nM 
Probe AAGGACTCATGACCACAGTCCATGCC 200nM 
 
Table 17. Ready-made mixes for real time PCR. All ready-made mixes were obtained from 
Life Technologies. 
Gene Assay code 
CD151 HS00911635_g1 
TIMP3 HS00165949_m1 
 
 
The enzyme Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a 
housekeeping gene and was used as reference in all RT-PCR experiments. All of the 
following reagents, without cDNA template, were added to an Eppendorf tube to 
make a master mix for the number of samples and mixed by vortexing: 
 
Table 18. Reagents of RT-PCR 
Reagent Amount (µl) 
SensiMix II Probe kit 5  
TaqMan MMP-7 primer mix   0.5 
TaqMan GAPDH primer mix 0,5  
cDNA 1 
Distilled water  3 
 
1. The master mix was divided amongst Eppendorf tubes containing the template 
samples and mixed by pipetting. The negative control contained H20 instead of 
cDNA 
2. Samples were transferred in triplicates to a 96 Well PCR plate 
3. Amplification was performed using the LightCycler 480 instrument. The 
following program was used: 
 
 
Table 19. RT-PCR protocol 
1 cycle 95°C 10 min 
50 cycles 
95°C 15 sec 
60°C 60 sec 
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2.7 Protein related techniques 
2.7.1 Enzyme linked immunosorbent assay 
All reagents were brought to room temperature before using them. 
 
1. The Capture Antibody was diluted to the working concentration (1:180) in PBS 
without carrier protein. 
2. Immediately a 96-well micro plate was coated with 100µl per well of diluted 
capture antibody. 
3. The plate was sealed and incubated overnight at room temperature. 
4. The capture antibody was aspirated from the plate and each well was washed 
with 200µl wash buffer (PBS with tween 20 0.01%) 4 times. 
5. Any remaining wash buffer was removed by inverting the plate and blotting it 
against clean paper towels. 
6. The plate was blocked by filling to each well 100µl of Reagent Diluent ( 1% BSA 
in PBS, pH 7,2-7,4) and incubating it for 1 hour at room temperature. 
7. The Reagent Diluent was aspirated from the wells. 
8. 100µl of the Reagent diluent were added per well for standard and 50µl of 
Reagent diluent for samples. 
9. 50µl of sample or 100µl of standard (pipetted in a serial dilution) were added in 
the Reagent diluent per well. 
10. The plate was covered with an adhesive strip and incubated for 2 hours at room 
temperature. 
11. Reagents were aspirated from the plate and each well was washed with 200µl 
wash buffer (PBS with tween 20 0.01%) 4 times. 
12. 100µl of detection antibodies (1:180) were added in each well and the plate was 
incubated for 2 hours. 
13. Reagents were aspirated from the plate and each well was washed with 200µl 
wash buffer (PBS with tween 20 0.01%) 4 times. 
14. 100µl of a conjugated human specific cytokine (Streptavidin-HRP) was added to 
each well. 
15. The plate was covered and incubated for 20 minutes at room temperature. 
Placing the plate in direct light was avoided. 
16. Reagents were aspirated from the plate and each well was washed with 200µl 
wash buffer (PBS with tween 20 0.01%) 4 times. 
17. 100µl of substrate solution (1:1 mixture of H2O2 and tetramethybenzidine) was 
added to each well. 
18. The plate was covered and incubated for 10-20 minutes, depending on the blue 
color development, at room temperature. Direct light to the plate was avoided. 
19. 50µl of stop solution (2N H2SO4) was added to each well to stop the reaction. 
The plate was gently tapped to ensure thorough mixing. 
20. The optical density was determined of each well immediately, using a micro plate 
reader at 450nm. 
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2.8 Functional assay 
2.8.1 Antibody based human MMP-7 activity assay 
Day 1  
 
Coating the RAG microtiter plate with anti-MMP-7:  
 
1. The antibody stock-solution was diluted 100x with the assay buffer (100 μl 
stock + 10 ml assay buffer)  
2. Immediately, a 96-well micro plate was coated with 100µl per well of diluted 
capture antibody. 
3. The plate was incubated 2 hours at 37°C in a humidified chamber. 
4. The coating solution was removed, and the plate was washed 4 times with 
wash buffer 
 
Preparing the standard curve 
 
1. 950 μl of assay buffer was added to the standard vial and gently mixed (32 
ng/ml stock). The following standard curve was used: 
 
32000 pg/ml = stock solution 
16000 pg/ml  = 250 μl 32 ng/ml + 250 μl buffer 
8000   pg/ml  = 250 μl 16 ng/ml + 250 μl buffer 
4000   pg/ml  = 250 μl 8 ng/ml + 250 μl buffer 
2000   pg/ml  = 250 μl 4 ng/ml + 250 μl buffer 
1000   pg/ml  = 250 μl 2 ng/ml + 250 μl buffer 
500     pg/ml  = 250 μl 1 ng/ml + 250 μl buffer 
250     pg/ml  = 250 μl 0.5 ng/ml + 250 μl buffer 
125     pg/ml  = 250 μl 250pg/ml + 250 μl buffer 
62,5    pg/ml  = 250 μl 125pg/ml + 250 μl buffer 
31,25  pg/ml  = 250 μl 62,5pg/ml + 250 μl buffer 
15,62  pg/ml = 250 μl 31,25pg/ml + 250 μl buffer 
0         pg/ml = 500 µl buffer 
 
2. Samples were diluted in the assay buffer (1:2) 
3. 100 µl of blank assay buffer, standard or sample were added to the wells. 
4. The plate was incubated overnight at 4°C in a humidified chamber. 
 
Day 2 
 
1. Preparing p-Aminophenyl mercuric acetate (APMA) 
APMA was prepared in order to activate the MMP-7 proteins used as standard  
 
o 50 μl of Dimethyl Sulphoxide (DMSO) were added to the vial and vortexed 
until the solution was clear → concentrated APMA solution (1 M) 
o 5 μl from the 1 M APMA solution were added to a vial containing 5 ml of 
assay buffer at room temperature and vortexed → ready to use APMA 
solution (1 mM) 
 
2. Wells were emptied 
3. Wells were washed 4 times with the wash buffer  
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4. 50 µl of the ready to use APMA solution (1 mM) was pipetted into wells 
containing standards  
5. 50 µl of assay buffer was pipetted into wells containing samples in which 
active MMP-7 was to be measured.  
6. Detection reagent was prepared with the following reagents 
 5.5 ml detection reagent:  
 4070 μl assay buffer  
 550 μl detection enzyme  
 880 μl chromogenic substrate  
 
7. 50 μl of the detection reagent were pipetted into all wells. 
8. The plate was shaken for 20 seconds  
9. The absorbance was measured at 405nm at t = 0, then covered and incubated 
at 37 ºC in a humidified chamber.  
10. After 6 and 24 hours of incubation the absorbance was measured at 405nm 
again.  
11. Depending on the sample's activity different standard lines for the calculation 
were used (for highly active samples the standard curve from 6h, for less 
active samples the standard curve from 24h). 
12. A graph of the absorbance at 405nm for the standards was plotted and a best-
fit standard curve was drawn. Using the most suitable standard curve, the 
A405 values of the samples could be calculated to pg/ml MMP-7, according to 
the polynomial equation that describes the curve. 
2.9 Statistical analysis 
The significance of a difference between two groups of experimental data in RT-PCR, 
ELISA, and activity assay analysis was determined using a paired two-tailed t-test 
calculated with Microsoft Office Excel 2007. A p-value of less than 0.05 was 
considered to be statistically significant. 
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3 RESULTS 
3.1 RT-PCR analysis of the effect of titanium on the MMP-7 mRNA expression 
in differentially activated macrophages 
3.1.1 Selection and optimization of MMP-7 specific primers 
The analysis of MMP-7 mRNA expression requires primers with an optimal 
amplification rate in order to obtain an exponential amplification curve as well as high 
specificity to avoid amplification of MMP-7 similar sequences. In order to achieve this 
specificity, three primer pairs for the MMP-7 gene were pre-selected with the primer 
design software tool on the website www.genscript.com. As the first primer tests were 
not specific and showed smearing in agarose gel after PCR, other primers using 
stricter criteria for the pre-selection were selected. Criteria were primer length 
between 18-24bp, a GC content between 40-60%, non-complementarity as well as 
similar melting temperatures. To avoid primer-dimers, particularly at their 3' end 
primers should not be complementary (84). Figure 4 shows the results of agarose gel 
electrophoresis performed with the PCR products from the two best working primers 
showing the highest specificity. It displays clear bands with the expected amplicon 
sizes of 74bp and 103bp. These two bands are fragments from two different parts of 
the MMP-7 gene. Their size is predefined as the sequence of MMP-7 gene, and the 
sequence of the primers is known. The aim was to identify the fragment which has 
the highest efficiency and specificity. The Primer pair with the amplicon size of 103bp 
was chosen for RT-PCR as it exhibits the brightest refulgence indicating a high 
amplification efficiency. Specificity of the primers is demonstrated as there are no 
other bands or smearing visible. In a second step, the required concentrations of 
primers and probe were optimized. For this purpose, a concentration gradient in RT-
PCR was performed, as indicated in material and methods. Concentrations with the 
earliest and steepest rise were selected and are shown in material and methods 
(Table 16. Primers and probe for real-time PCR) 
 
 
 
Figure 4. Electrophoretic analysis of amplified MMP-7 fragments in the agarose gel. 
Efficiency and specificity of two different MMP-7 primer pairs were tested with PCR and agarose gel 
electrophoresis (lane 2 and lane 4). Negative controls were prepared with H2O for each primer pair 
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(lane 3 and lane 5). A DNA-ladder (Lane 1) was used in order to identify the expected sizes of the 
MMP-7 gene fragments (74bp and 103bp). The primer pair in lane 4 was chosen for further analysis in 
RT-PCR, as it showed the brightest and clearest band as well as no smearing. 
3.1.2 Porous titanium induces MMP-7 mRNA in M0 and M2 macrophages 
In order to examine the effect of titanium surfaces on the expression of MMP-7 in 
differentially activated macrophages a test system established in our laboratory was 
used. For 6 days, human peripheral blood monocytes were cultured either on plastic 
or on titanium disks as well as stimulated with different cytokines in order to 
differentiate them in M1 (IFNg), M2 (IL4) or M0 (no stimulation) macrophages. 
Initially, the expression of MMP-7 was analyzed on the level of mRNA by RT-PCR 
from cells harvested on day 6 of cultivation. cDNA samples were partially provided by 
Alexandru Gudima (BC-726-3, BC-726-6, BC-729-1, BC-729-4, BC-747-3, BC-751-1, 
BC-754-1, BC-756-2, BC-757-1, BC-758-1). cDNA from the samples BC-713-1 and 
BC-713-2 were synthesized in own work. The expression of MMP-7 mRNA was 
examined for macrophage cultures from 12 individual donors. 
Titanium induced MMP-7 mRNA in 11 out of 12 analyzed donors in M0 and in all 12 
donors in M2 (Figure 5 A, C). The fold change induced by titanium ranged between 
1,00 to 266,31 in M0 and between 5,6 to 507,99 in M2 macrophages (Table 20). 
A fold-change of 2 means a change to 2 times. Interestingly, M1 macrophages 
exhibited a different pattern of MMP-7 expression. In these macrophages, titanium 
induced MMP-7 expression in 6 out of 12 donors, suppressed MMP-7 expression in 5 
out of 12 donors and showed no effect in 1 out of 12 donors (Figure 5 B). 
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Figure 5. RT-PCR analysis of the effect of porous titanium on MMP-7 mRNA in 
differentially activated macrophages. Analysis of MMP-7 mRNA levels was performed for 3 
subpopulations of macrophages of 12 individual donors: M0(A), M1(B) and M2(C), cultured on plastic 
(control, light gray) or on porous titanium disks (dark grey) for 6 days. Individual donors are indicated 
with buffy coat numbers. All experiments were performed in triplicates. Data were normalized to the 
control of M0 of BC 729-4 by dividing each sample's target/reference value through it. Hence M0 BC 
729-4 (control) has a relative expression of 1. Error bars: Standard deviation 
 
Given that the individual donors revealed clear differences between titanium and 
control groups, it was of interest to analyze whether the mean values can be 
discriminated with statistical significance. For this purpose, a two-tailed t-test was 
performed. M0 and M2 macrophages could be discriminated in titanium and control 
group with a significant difference of p=0,006 and p=0,0009. In turn, M1 
macrophages displayed no difference between control and titanium samples (Figure 
6). The general expression of MMP-7 in M1 macrophages cultured on plastic 
(control) was lower than in M0 and M2, however without showing statistical 
significance. 
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Figure 6. Statistical analysis of the effect of porous titanium on MMP7 gene 
expression.  
Analysis of MMP-7 mRNA levels was performed for 3 subpopulations of macrophages of 12 individual 
donors: M0 (A), M1 (B) and M2 (C), cultured on plastic (control, light gray) or on porous titanium disks 
(dark grey) for 6 days. For statistical analysis Student’s paired T-test was used. All experiments were 
performed in triplicates. Statistical analysis was performed out of individual donors in Figure 5. Error 
bars: Standard error of the mean. 
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3.1.3 Polished titanium induces MMP-7 mRNA in M0, M1 and M2 macrophages. 
Due to the highly significant results of the experiment using titanium disks with pores, 
it was of interest if the results would be different using titanium with a polished 
surface, which is also widely used in implant industry. The experiment with polished 
titanium disks was designed in the same way as the experiment using porous 
titanium. 
Similar to the experiment with porous titanium, a significant difference between 
titanium and control group in M0 and M2 macrophages was observed. MMP-7 was 
induced in 7 out of 10 cases in M0 and in 10 out of 10 in M2 macrophages (Figure 7 
A, C). The three donors in M0 whose MMP-7 is reduced by titanium expressed both 
in control and titanium stimulated group a very low MMP-7 expression (relative 
expression ranging from 0,01 to 0,60), and also the reducing effect of titanium 
(decrease of fold ranging from 0,9 to 0,04) was meager in these three samples, 
indicating a minor relevance of the MMP-7 reduction by titanium in these donors 
(Figure 7 A). In contrast, in macrophages of donors where titanium induced MMP-7, 
an increase of fold ranging from 1,85 to 15,64 in M0 and from 1,85 to 137,54 in M2 
could be determined. In contrast to the experiments with porous titanium, M1 
macrophages expressed higher levels of MMP-7 in 8 out of 10 donors when cultured 
on polished titanium (Figure 7 B). The mean values in the M1 macrophage group 
demonstrated statistical significance, which is different from the results of porous 
titanium experiments where no statistical significance in the M1 group was shown 
(Figure 8).   
Collectively, the performed experiments with porous and polished titanium suggest a 
different response of macrophage subtypes as a function of the implemented titanium 
type. 
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Figure 7. RT-PCR analysis of the effect of polished titanium on MMP-7 mRNA in 
differentially activated macrophages. Analysis of MMP-7 mRNA levels was performed for 3 
subpopulations of macrophages of 10 individual donors: M0(A), M1(B) and M2(C), cultured on plastic 
(control, light gray) or on polished titanium disks (dark grey) for 6 days. Individual donors are indicated 
with buffy coat numbers. All experiments were performed in triplicates. Data were normalized to the 
control of M0 of BC 729-4 by dividing each sample's target/reference value through it. Hence M0 BC 
729-4 (control) has a relative expression of 1. Error bars: Standard deviation 
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Figure 8. Statistical analysis of the effect of polished titanium on MMP7 gene 
expression. Analysis of MMP-7 mRNA levels was performed for 3 subpopulations of macrophages 
of 10 individual donors: M0(A), M1(B) and M2(C), cultured on plastic (control, light gray) or on polished 
titanium disks (dark grey) for 6 days. For statistical analysis Student’s paired T-test was used.  All 
experiments were performed in triplicates. Statistical analysis was performed out of individual donors 
in Figure 7. Error bars: Standard error of the mean. 
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3.2 ELISA analysis of the effect of titanium on the MMP-7 protein expression 
in differentially activated macrophages. 
Since RT-PCR analysis revealed a significant effect of titanium on MMP-7 gene 
expression, the next step was to identify whether this effect is consistent on the 
protein level. Supernatants of macrophage cultures for the same 12 donors were 
harvested on day 1, 3 and 6 and MMP-7 concentrations were analyzed by ELISA. 
3.2.1 Dynamic accumulation of MMP7 secreted by macrophages during the 
differentiation on titanium disks 
In order to quantify at which time of incubation the highest amount of MMP-7 is 
expressed, supernatants of four donors stimulated with porous titanium were 
analyzed by ELISA which were harvested on day 1, 3 and 6 of macrophage 
cultivation. As displayed in Figure 9, MMP-7 protein increased in all macrophage 
subpopulations during the period of incubation. The highest amount of MMP-7 
protein levels could have been stated on day 6. In order to quantify this increase 
during the duration of incubation, fold changes of MMP-7 secretion from day 1 to day 
6 were calculated. In the control group, an increase of fold ranging from 1,37 up to 
2,03 in M0 (Figure 9A) was observed, from 2,71 up to 7,18 in M1 (Figure 9B) and 
from 1,00 up to 14,98 in M2 macrophages (Figure 9C). In samples stimulated with 
porous titanium, the increase of fold ranged from 1,56 up to 11,60 in M0, from 0,75 
up to 1,99 in M1, and from 6,47 up to 28,12 in M2 macrophages. M1 macrophages of 
one donor stimulated with titanium, secreted less MMP-7 on day 6 than on day 1. 
MMP-7 in M0 and M2 macrophages, stimulated by porous titanium, showed a 
stronger increase of fold by the duration of incubation than their controls. In contrast, 
MMP-7 of M1 macrophages was stronger induced in the control group. On day 1, 
titanium did not affect the MMP-7 secretion, and the effect on MMP-7's fold-change 
was mostly pronounced between day 3 and day 6. 
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Figure 9. ELISA analysis of MMP-7 protein secretion in differentially activated 
macrophages. Analysis of MMP-7 protein levels was performed for 3 subpopulations of 
macrophages of 4 individual donors: M0(A), M1(B) and M2(C), cultured on plastic (control, left column) 
or on porous titanium disks (right column) for 6 days. Individual donors are indicated with buffy coat 
numbers. Supernatants were collected on day 1, 3 and 6 of macrophage cultivation. All experiments 
were performed in duplicates. 
3.2.2 Porous titanium induces MMP-7 protein expression in M0 and M2 
macrophages 
Since MMP-7 secretion was mostly pronounced on day 6, it was of interest how 
protein levels of the other donors were affected by titanium after 6 days of incubation. 
Regarding M0 and M2 macrophages, donors showed a similar response to titanium 
on protein level when compared to the mRNA level. Titanium induced MMP-7 protein 
in 11 out of 12 donors analyzed in M0 and in 10 out of 12 in M2 (Figure 10 A, C). In 
M1 macrophages 5 out of 12 donors showed higher secretion of MMP-7, while 6 out 
of 12 suppressed the secretion of MMP-7 in response to titanium. One donor showed 
no effect on titanium (Figure 10 B). 
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Figure 10. ELISA analysis of the effect of porous titanium on MMP-7 protein in 
differentially activated macrophages of individual donors. Analysis of MMP-7 protein levels 
was performed for 3 subpopulations of macrophages of 12 individual donors M0(A), M1(B) and M2(C), 
cultured on plastic (control, light gray) or on porous titanium disks (dark grey) for 6 days. Individual 
donors are indicated with buffy coat numbers. The analysis was performed from supernatants 
collected on day 6 of macrophage cultivation. All experiments were performed in duplicates. Error 
bars: Standard deviation. 
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Statistical analysis for the secreted levels of MMP-7 as measured by ELISA 
demonstrated a significant induction by titanium in M0 (p=0,04) and M2 macrophages 
(p=0,03) (Figure 11). The Data of M0 and M2 macrophages corresponds to the 
results of the RT-PCR analysis, where a significant induction by titanium was noted 
as well. In the M1 group, a non-significant reduction of MMP-7 was observed 
(p=0,06). However, the levels of secreted MMP-7 in M1 are so low that they have 
probably no biological relevance.  
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Figure 11. Statistical analysis of the effect of porous titanium on MMP-7 protein 
secretion. Analysis of MMP-7 protein levels was performed for 3 subpopulations of macrophages of 
12 individual donors: M0(A), M1(B) and M2(C), cultured on plastic (control, light gray) or on porous 
titanium disks (dark grey) for 6 days. Statistical analysis was performed from supernatants collected 
on day 6 of macrophage cultivation (Figure 10). For statistical analysis Student’s paired T-test was 
used. All experiments were performed in duplicates. Error bars: Standard error of the mean.  
 
 
3.3 Antibody-based analysis of active MMP-7 protein secretion in differentially 
activated macrophages. 
3.3.1 Analysis of active MMP-7 secretion in titanium stimulated macrophages. 
As MMP-7 can be secreted in an active and an inactive form (46), it was of interest to 
examine if titanium stimulated macrophages also express the active form of MMP-7. 
Therefore, an activity assay, based on ELISA method was performed. Supernatants 
from macrophages cultured with and without titanium were analyzed after incubation 
with a pro-enzyme which, upon activation by active MMP-7, can release color from a 
chromogenic peptide substrate. Active MMP-7 concentration was measured 
photometrically. It was identified that cultivation of M0 and M2 macrophages on 
titanium disks resulted in the production of elevated levels of active MMP-7 in 10 out 
of 11 donors and in 5 out of 11 donors in M1 (Figure 12).  
Absolute levels of active MMP-7 showed a strong variation among macrophage 
subtypes. M2 macrophages stimulated with titanium expressed the highest levels of 
MMP-7 among the macrophage subtypes (mean: 687,3 pg/ml; range of between 0-
2916,2 pg/ml). M1 macrophages expressed the lowest levels of MMP-7 out of all 
macrophage subtypes with a mean concentration of 37,7 pg/ml and a range of 
between 0-174,1 pg/ml under titanium stimulation. M0 macrophages ranged in the 
middle with a mean activity of 285,5 pg/ml and a range of between 0-2134,8 pg/ml 
under titanium stimulation. Active MMP-7 concentrations secreted from macrophages 
without titanium stimulation were low in general (mean activity: M0 (18,3), M1(40,6) 
and M2 (20,8)) Range was between 0-197,1 pg/ml.  
Active MMP-7 was induced in M0 and M2 macrophages derived from monocytes 
isolated from 10 out 11 individual donors, however without statistical significance 
(p=0,18 for M0 and p=0,06 for M2, (Figure 13)).  
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Figure 12. Antibody-based analysis of active MMP-7 protein in differentially activated 
macrophages. Analysis of MMP-7 protein levels was performed for 3 subpopulations of 
macrophages of 11 individual donors: M0, M1, and M2 cultured on plastic (control) or porous titanium 
disks for 6 days. Individual donors are indicated with buffy coat numbers. The analysis was performed 
from supernatants collected on day 6 of macrophage cultivation. A405 was measured at 6h and 24h 
after capturing MMP-7 with specific antibodies and incubating it with a chromogenic substrate which 
was degraded only by active MMP-7. Concentrations of active MMP-7 were calculated with a standard 
curve. For statistical analysis Student’s paired T-test was used.  All experiments were performed in 
duplicates. Error bars: Standard deviation. 
 
 
 
Figure 13. Statistical analysis of the effect of porous titanium on the active MMP-7 
protein secretion. 
 Analysis of MMP-7 protein levels was performed for 3 subpopulations of macrophages of 11 
individual donors: M0, M1, and M2 cultured on plastic (control) or porous titanium disks for 6 days. 
Statistical analysis was performed from the supernatants collected on day 6 of macrophage cultivation 
(Figure 12). A405 was measured at 6h and 24h after capturing MMP-7 with specific antibodies and 
incubating it with a chromogenic substrate which was degraded only by active MMP-7. Concentrations 
of active MMP-7 were calculated with a standard curve. For statistical analysis Student’s paired T-test 
was used.  All experiments were performed in duplicates. Error bars: Standard error of the mean. 
 
0
500
1000
1500
2000
2500
3000
3500
Control Titanium Control Titanium Control Titanium
M0 M1 M2
pg
/m
l
BC-713-2
BC-726-3
BC-726-6
BC-729-1
BC-729-4
BC-747-3
BC-751-1
BC-754-1
BC-756-2
BC-757-1
BC-758-1
0
200
400
600
800
1000
1200
Control Titanium Control Titanium Control Titanium
M0 M1 M2
pg
/m
l
n=11
p=0,06
Results 
 48 
3.3.2 Percentage of active MMP-7 secretion in macrophages of individual donors. 
In order to identify whether titanium in addition to the induction of MMP-7 secretion 
affects MMP-7 activation, the percentage of active MMP-7 both in control and 
titanium stimulated group was calculated (Figure 14). This is necessary as higher 
levels of active MMP-7 in titanium stimulated macrophages (Figure 12) may also be a 
result of higher levels of total MMP-7 in this group. Therefore, the total MMP-7 protein 
of an individual donor, measured in ELISA, was divided by its active form of MMP-7, 
measured in the activity assay, and was multiplied with one hundred. 
Active form of MMP-7 was between 0,7% and 84,2% in control macrophages and 
between 2,7% and 53,1% in macrophages cultivated on titanium. MMP-7 protein of 
macrophages was considered as activated by titanium when the percentage of 
activation in macrophages cultured on titanium was higher than in macrophages 
cultured on plastic. In macrophages cultured on titanium 6 out of 11 analyzed donors 
in M0, 5 out of 11 in M1 and 7 out of 11 in M2 exhibited induction of their activity 
under titanium stimulation (Figure 14). 
Mean values between control and titanium stimulated groups of all macrophage 
subtypes showed no significant difference (data not shown).  
 
 
 
 
 
 
 
Figure 14. The percentage of MMP-7 in the active form for 11 donors.  
Percentage of active MMP-7 was calculated by dividing the concentrations of active MMP-7 protein, 
measured in the activity assay, by the total protein concentrations, measured in ELISA. 
 
3.4 The effect of titanium on MMP-7 mRNA, protein and activity  
In order to identify the extent to which titanium affects mRNA, protein and active 
protein expression, fold-changes between titanium and control groups were 
calculated (Table 20). Empty fields indicate donors who could not be calculated, as 
either the control or the titanium stimulated sample showed no expression. Therefore, 
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macrophages of some donors reacted on titanium, but fold-changes could not be 
calculated. 
As MMP-7 expression is regulated on different levels, it is of interest on which level of 
regulation the titanium induction is more pronounced. For this purpose, fold changes 
in mRNA, total protein and active protein were calculated separately and 
subsequently compared with each other.  
Induction of MMP-7 mRNA in macrophages derived from individual donors in general 
correlated with the induction on protein level, and partially on the activity level (Table 
20). 
M1 macrophages exhibit only very low fold-changes so that they have probably no 
biological relevance. 
MMP-7 was only considered as “induced” on a certain level of regulation if the fold-
change on this level was higher than on the previous level. This is because MMP-7 
protein is a result of MMP-7 mRNA and active MMP-7 a result of pro-MMP-7, 
measured in ELISA. 
In M0 macrophages of 11 out of 12 donors, titanium induced MMP-7 on mRNA level, 
although the fold change of one donor could not be calculated as the control sample 
showed no expression (BC-757-1). 6 out of 11 of these donors were also induced on 
protein level and 1 out of these 6 donors also on activity level (BC-713-2). In M2 
macrophages, of 12 out of 12 donors, titanium induced MMP-7 on mRNA level, 
although the fold change of one donor could not be calculated, as the control sample 
showed no expression (BC-758-1). 6 out of 12 of these donors were also induced on 
protein level and 1 out of these 6 donors also on activity level (BC-726-6). (Table 20).  
 
Induction was considered as “more pronounced” on a certain level of regulation when 
the fold change was more than the double of the previous level of regulation. In M0 
macrophages of 7 out of 12 donors analyzed, and in M2 macrophages of 8 out of 12 
donors analyzed, the induction on MMP-7 on the mRNA level was more pronounced 
than on the protein level, whereas the other donors exhibited a higher induction on 
protein level.  
 
 
Table 20. Fold-changes of MMP-7 gene expression, protein secretion, and activity 
affected by titanium. Values were calculated by dividing the MMP-7 expression of macrophages 
cultured on titanium disks by the MMP7 expression of macrophages cultured on plastic (control). 
 
 M0 M1 M2 
 mRNA Protein activity mRNA Protein activity mRNA Protein activity 
BC-713-1 22,09 19,30 - 1,70 0,23 - 26,32 130,52 - 
BC-713-2 13,61 38,30 72,23 1,70 1,45 1,12 46,21 353,36 29,20 
BC-726-3 3,01 9,10 4,25 - - - 8,26 15,08 - 
BC-726-6 4,49 8,14 6,01 1,69 0,21 0,59 6,89 9,03 39,77 
BC-729-1 3,41 1,59 - 0,10 0,26 0,16 9,73 3,64 - 
BC-729-4 1,00 1,36 6,55 1,38 0,09 - 17,10 9,34 9,38 
BC-747-3 5,64 19,77 7,69 3,77 0,64 0,88 60,49 312,01 78,92 
BC-751-1 27,19 1,85 - 0,01 0,21 0,00 75,74 6,53 - 
BC-754-1 266,31 1123,18 - 3,25 1,32 0,49 507,99 - 136,45 
BC-756-2 5,16 6,19 1,57 0,43 1,15 0,16 5,60 9,11 3,98 
BC-757-1 - 1,78 - - 1,30 0,48 8,80 3,77 6,23 
BC-758-1 1,43 0,80 1,41 0,19 1,00 1,39 - 0,95 8,61 
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3.5 RT-PCR analysis of the effect of titanium on MMP-7 regulators in 
differentially activated macrophages 
Since the effect of titanium on the level of MMP-7 protein production and the 
activation of MMP-7 were different for individual donors, it was of interest to analyze 
whether titanium influences the regulators of MMP-7 and orchestrates the activity of 
MMP-7. One inhibitor (TIMP-3) and one activator (CD151) of MMP-7 were chosen for 
RT-PCR analysis. It was hypothesized, that these MMP regulators are induced or 
suppressed by titanium. TIMP-3 and CD151 were chosen, as human macrophages 
express them and the difference in the expression levels of TIMP-3 and CD151 were 
previously identified using Affymetrix gene expression analysis. In the Affymetrix 
analysis an up-regulation of CD151 and a down-regulation of TIMP-3 was identified 
in macrophages cultured on titanium. However, only with statistical significance for 
CD151 (Alexandru Gudima, Affymetrix data) (82). 
3.5.1 Involvement of TIMP-3 in the regulation of MMP-7 activity  
TIMP-3 has the broadest spectrum of MMP inhibition out of all TIMP's (18), and it 
inhibits MMP-7 by binding it in a 1:1 stoichiometry. It was hypothesized that TIMP-3 is 
down-regulated in macrophages cultured on titanium leading to the up-regulation of 
MMP-7 activity.  
Using RT-PCR it was found that TIMP-3 expression is not significant decreased in 
M1 and M2 macrophages cultured on titanium (Figure 15), (2,02 fold change in M2 
and 9,36 fold change in M1). In M0 macrophages, cultivation on titanium had a 
stimulating effect on TIMP-3 expression (p=0,08). As there was a tendency but no 
significance for down-regulation in M1 and M2, individual donors which were 
activated by titanium were examined (Figure 14). Active MMP-7 was induced in M2 
macrophages of 7 out 11 donors (Figure 14). In 4 out of these 7 donors (BC-726-3, 
BC-726-6, BC-729-1, BC-754-1) TIMP-3 was down-regulated, suggesting a 
mechanism of activity regulation (Figure 16). In M1 macrophages 5 out of 11 donors 
were induced by titanium (Figure 14). 2 out of 5 of these donors (BC 747-3, BC 758-
1) showed a down-regulation of TIMP-3.  
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Figure 15. Statistical analysis of the effect of porous titanium on TIMP3 mRNA 
expression. Analysis of MMP-7 mRNA levels was performed for 3 subpopulations of macrophages 
of 11 individual donors: M0, M1 and M2 cultured on plastic (control, light gray) or porous titanium disks 
(dark grey) for 6 days. For statistical analysis Student’s paired T-test was used.  All experiments were 
performed in triplicates. Error bars: Standard error of the mean. 
 
 
 
 
Figure 16. RT-PCR analysis of the effect of porous titanium on TIMP-3 mRNA 
expression in differentially activated macrophages. Analysis of TIMP-3 mRNA levels was 
performed for 3 subpopulations of macrophages of 11 individual donors: M0, M1 and M2 cultured on 
plastic (control) or porous titanium disks for 6 days. Individual donors are indicated with buffy coat 
numbers. All experiments were performed in triplicates. Data were normalized to the control of M0 of 
BC 729-4 by dividing each sample's target/reference value through it. Hence M0 BC 729-4 (control) 
has a relative expression of 1. Error bars: Standard deviation. 
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3.5.2 Involvement of CD151 in the regulation of MMP-7 activity  
Shiomi et al. were able to provide evidence for high proteolytic activity of MMP-7 in 
case of co-localisation with CD151. However, as CD151 has no proteolytic activity 
itself, it was considered that it activates MMP-7 indirectly by binding it to the cell 
surface and facilitating the proteolysis of its pro-peptide by other MMP activators (85). 
It was of interest whether differentially expressed levels of CD151 could explain the 
up-regulation of activity of MMP-7 in macrophages cultured on titanium. 
In M0 macrophages cultured on titanium, a slightly enhanced (2,55 vs.1,93) but not 
statistically significant (p=0,38) expression of CD151 was detected suggesting a 
potential contribution of CD151 to the MMP-7 regulation (Figure 17). Likewise, for 
CD151 individual donors which are activated by titanium (Figure 14) were examined. 
Active MMP-7 was induced in M0 macrophages of 6 out 11 donors (Figure 14). In 3 
out of these 6 donors (BC-729-4, BC 751-1, 758-1) an upregulation of CD151 was 
observed (Figure 18). In M1 macrophages, no difference in CD151 mRNA levels was 
found. In M2, a not significant down-regulation of CD151 gene expression was 
detected in macrophages cultured on the titanium disks (p=0,37).  
 
 
 
 
Figure 17. Statistical analysis of the effect of porous titanium on CD151 gene 
expression for macrophages. Analysis of MMP-7 mRNA levels was performed for 3 
subpopulations of macrophages of 11 individual donors: M0, M1 and M2 cultured on plastic (control, 
light gray) or porous titanium disks (dark grey) for 6 days. For statistical analysis Student’s paired T-
test was used. All experiments were performed in triplicates. Error bars: Standard error of the mean. 
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Figure 18. RT-PCR analysis of the effect of porous titanium on CD151 mRNA 
expression in differentially activated macrophages. Analysis of CD151 mRNA levels was 
performed for 3 subpopulations of macrophages of 11 individual donors: M0, M1 and M2 cultured on 
plastic (control) or porous titanium disks for 6 days. Individual donors are indicated with buffy coat 
numbers. All experiments were performed in triplicates. Data were normalized to the control of M0 of 
BC 729-4 by dividing each sample's target/reference value through it. Hence M0 BC 729-4 (control) 
has a relative expression of 1. Error bars: Standard deviation. 
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4 DISCUSSION 
4.1 The production of MMP-7 in response to titanium 
Titanium is the metal of choice regarding the implementation of prosthetics, dental 
implants, medical devices and in general for intraosseous use in medical fields. The 
material has been used for decades and offers advantages with respect to 
biocompatibility, corrosion resistance and mechanical properties (86). Nevertheless, 
aseptic implant failure of titanium implants can occur and may cause severe 
problems for health and life quality of the patient (87). It has been reported that 3,4-
9% of orthopedic implants fail (88, 89). Regarding the reasons for failure, aseptic 
implant loosening is responsible for more than 80% of the carried out revision 
operations in the field of endoprosthesis (90). MMP’s, in general, are considered to 
play a crucial role in periprosthetic loosening (3). Macrophages play a vital role in 
inflammatory processes and present a primary source of MMPs (Table 4). Thus, it is 
of interest to analyze how this cell type expresses MMPs after being exposed to 
titanium. The response of differentially activated pro-inflammatory M1 macrophages, 
anti-inflammatory M2 macrophages and M0 macrophages has been analyzed. The 
focus was on MMP-7 as preliminary Affymetrix chip microarray analysis (performed 
by Alexandru Gudima (82)), showed the strongest induction by titanium out of all 
MMPs. Additionally, MMP-7’s broad substrate spectrum indicates for a high biological 
relevance (21).  
The quantitative RT-PCR performed in the current study has confirmed the 
microarray analysis and demonstrated a significant induction of MMP-7 in M0 and M2 
macrophages on mRNA and protein level. The active form of MMP-7 was induced in 
M0 and M2 macrophages derived from monocytes isolated from 10 out of 11 
individual donors. Although there was no statistical significance (p=0,18 for M0 and 
p=0,06 for M2) the results indicate for relevant higher concentrations of active MMP-7 
secreted by macrophages stimulated with titanium. The non-significant results can be 
explained by the high variability of MMP-7 concentrations among macrophages 
derived from individual donors, resulting in large standard errors. Nevertheless, a 
tendency for higher levels of active MMP-7 both in M0 and M2 macrophages was 
observed. 
 
In order to identify whether titanium affects MMP-7 activation, the percentage of 
activation was calculated as described in results.  
Titanium induced MMP-7 in 50-60% of the donors (6 out of 11 analyzed donors in 
M0, 5 out of 11 in M1 and 7 out of 11 in M2), meaning these donors showed a higher 
percentage of activation in titanium stimulated macrophages compared to 
macrophages without stimulation. Statistical significance was not proven. The 
activation of MMP-7 is crucial as mainly the enzyme in its active form can cleave its 
numerous substrates (15). However, also MMPs in its pro-form (MMP-1, -9, -13, -14) 
were described as functionally active (6). If these findings from other MMPs are 
transferable to MMP-7 is not clear and has to be analyzed in further experiments.  
 
Other studies have also reported the up-regulation of MMP-7 expression and other 
MMPs by titanium. Yasuharu Nakashima et al. were able to demonstrate an 
enhanced production of MMP-1, MMP-2, and MMP-9 in primary human macrophages 
exposed to titanium alloy particles. In the same experiment, they also presumed the 
detection of MMP-7 in an analysis by zymography, due to its molecular weight and 
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the caseinolytic activity (66). Shubayev et al. reported an increase of MMP-7, -2 and -
9, detected by immunohistochemical analysis of rat tissue after the implementation of 
titanium implants (91). However, the levels of MMP-7 secreted by differentially 
activated macrophages cultured on titanium, as well as the effect of titanium on the 
three primary levels of regulation of MMP-7 production (gene expression, protein 
secretion, activation) have not been examined until now. 
Fold-changes between titanium and control groups were calculated, in order to 
identify the extent to which titanium affects mRNA, protein and active protein 
expression. It was also of interest if protein induction corresponds to mRNA induction 
and on which level of regulation the induction is most pronounced (Table 20). 
Both in M0 and M2 macrophages of 6 out of 12 donors, an induction of MMP-7 on 
mRNA followed by an induction on protein level was shown. One donor showed an 
induction on all three levels of regulation. Fold-changes of M1 macrophages were so 
low that they have probably no biological relevance. 
MMP-7 is to a greater extent induced on mRNA level (7 out of 12 in M0 and 8 out of 
12 in M2) which corresponds to the literature where it is described that the main part 
of MMP regulation is mostly attributed to the transcriptional level (1, 23, 24). 
However, it is not clear for which cell types these findings are relevant. Induction by 
titanium is shown on both levels of regulation. Whether MMP-7 is mainly induced on 
mRNA or protein level may also be donor specific. However, the main part of MMP-7 
induction is located on mRNA and protein level and not on activity level. 
 
As it was demonstrated in the experiments that MMP-7 is up-regulated differentially 
by titanium on all levels of regulation, it is of interest by which mechanisms and on 
which level of regulation titanium is able to induce MMP-7. Table 22 shows regulators 
of MMP-7 on different levels of regulation expressed by macrophages and other cell 
types. 
General mechanisms of MMP regulation, for instance, early response signal 
pathways on the transcriptional level, mRNA stabilization on post-transcriptional level 
or proteolytic activation have been reported previously.   
However, there are no studies so far reporting mechanisms where titanium interferes 
with the mRNA or protein syntheses of MMPs. Nevertheless, it is possible that 
titanium enhances the phosphorylation of transcription factors like AP-1, PEA3 NFK-
B and STAT, which are key transcription factors and essential in the regulation of 
MMP genes (23, 24). For instance, for MMP-1 it has been reported that inflammatory 
cytokines increase the levels of different AP-1 proteins via the MAPK signaling 
pathway (23). Similar mechanisms for MMP-7 may be possible. As titanium induces 
MMP-7 also on the protein level (Table 20). 
an influence on AU-rich binding proteins which play a central role in mRNA 
stabilization can be suggested. These proteins, of which approximately 20 have been 
identified to date, can either promote or impair rapid mRNA turnover or translation 
(92). MMP-9 contains several copies of AU-rich elements (23). Other MMPs 
containing these proteins have to be identified in further experiments. Also, Micro 
RNA and UTR binding proteins play important roles in the post-transcriptional 
regulation of MMP-7 (23, 26-28). A modification of these structures by titanium can 
be suggested as well.  
Statistical significance of MMP-7 activation by titanium could not be proven. 
However, some donors were activated by titanium (Figure 14), leading to an 
examination of MMP-7 activity regulators. In the experiments TIMP-3 and CD151, 
regulators of MMP-7 activity were examined.  They were selected for RT-PCR 
analysis, as preliminary Affymetrix gene chip analysis showed an up-regulation for 
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CD151 and a downregulation for TIMP-3 in titanium stimulated samples (A. Gudima, 
Affymetrix data (82)). It was hypothesized that a downregulation of TIMP-3 and an 
up-regulation of CD151 in titanium stimulated macrophages is a mechanism of 
activity regulation in macrophages stimulated with titanium. 
 
Analysis of the MMP-7 inhibitor TIMP-3 did not show a statistical significance of 
down-regulation in macrophages (Figure 15). However, a tendency of down-
regulation was observed in M1 and M2 macrophages, leading to an examination of 
those donors which were activated by titanium (7 out of 11 in M2 and 5 out 11 in M1, 
Figure 14).  4 out of 7 of these donors in M2 and 2 out of 5 of these donors in M1 
showed a downregulation of TIMP-3, suggesting a mechanism of activity regulation in 
these macrophage subtypes by titanium (Figure 14, Figure 16). 
Analysis of the MMP-7 activator CD151 did not show a significant up-regulation in 
macrophages, however a tendency of induction by titanium in M0 macrophages 
(Figure 17). Looking at individual donors in M0 macrophages, 6 out of 11 donors 
were activated by titanium and 3 out of 6 of these donors exhibited an upregulation of 
CD151 (Figure 14, Figure 18).  
Though, the analysis of CD151 mRNA does not show how much of the molecule will 
be localized to the cell surface where it is biologically relevant. For this analysis, 
immunostaining is required. Further studies analyzing regulating factors of MMP-7 
that depend on the presence of titanium should be performed. Collectively, TIMP-3 
and CD151 might be regulators of MMP-7 activity specific for macrophage subtypes 
as well as for individual donors.  
Further possible mechanisms of MMP-7 activation by titanium is the modification of 
the cysteine in the pro-domain, as it has already been described for heavy metal ions 
(7). 
In macrophages of samples where active MMP-7 was detected but no induction by 
titanium has been shown on the activation level, an auto-activation of MMP-7 can be 
expected which is independent of the presence of titanium (39). 
Additional factors which can affect MMP-7 expression up-regulation are shown in 
Table 22. All these factors may orchestrate MMP-7 expression and activity in vivo. 
The influence of titanium on them should also be examined in vivo experiments.  
 
ELISA analysis showed that MMP-7 increased by the time of incubation. After 6 days, 
a maximum of MMP-7 protein both in control and titanium groups was detected. The 
increase of fold was stronger in the titanium stimulated samples (Figure 9), which is 
consistent with, identified in this study, the ability of titanium to induce MMP-7. The 
increase of MMP-7 during the time of macrophage cultivation on titanium disks 
corresponds to the results obtained by Filippov et al. demonstrating that the 
concentration of MMP-7 in cultured macrophages was augmented by time and 
reached a plateau after 5 days (77). Therefore, titanium supports the accumulation of 
MMP-7 protein during the macrophage maturation. However, the variations of 
induction by titanium on the different levels of regulation (Table 20) suggest that 
titanium can affect expression or functional activation of the regulating factors (Table 
21). For instance, Lipopolysaccharides (LPS) found in the outer membrane of gram-
negative bacteria can induce MMP-7 mRNA and Protein in macrophages. Whether 
there are similar mechanisms for gram-positive bacteria which are more prevalent in 
implant infections has to be examined in further studies.  
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Table 21. Factors regulating MMP-7. 
Level & kind 
of regulation  
Receptor/Stimuli Mechanism Localization/
Method 
Cells/tissue Ref. 
Activity ↑ CD 151 Suggestion: 
Promotion of 
autoactivation 
by 
compartmentali
zation 
Pericellular/ 
cell surface 
Human rectal 
carcinoma, 
yeast 
(85) 
Activity ↑ trypsin Proteolytic 
cleavage at E77-
Y78 within the 
propeptide 
 
Purified 
ProMMP in 
SDS- Page 
Purified 
MMP-7 from 
Human rectal 
carcinoma 
cells 
 
(93, 
94) 
50% of 
Activity ↑ 
Plasmin & 
leukocyte 
elastase 
Proteolytic 
cleavage of 
propeptide 
 
 
 
Purified 
ProMMP in 
SDS-Page 
Purified 
MMP-7 from 
Human rectal 
carcinoma 
cells 
(94) 
Activity ↑ MMP-3 Proteolytic 
cleavage of 
propeptide 
 
Purified 
ProMMP in 
SDS-Page 
Purified 
MMP-7 from 
Human rectal 
carcinoma 
cells 
 
(94) 
Activity ↑ 4-
aminophenylmerc
uric acetat 
(APMA) 
Proteolytic 
cleavage at E77-
Y78 within the 
propeptide 
 
Purified 
ProMMP in 
SDS-Page 
Purified 
MMP-7 from 
Human rectal 
carcinoma 
cells as well 
as myeloma 
cells 
 
(93, 
94) 
Activity ↑ High temperature 
(53°C incubation: 
max activity after 
6h; 37°C 
incubation: max 
activity after 24h) 
Proteolytic 
cleavage at E77-
Y78 within the 
propeptide 
 
Purified 
ProMMP in 
SDS-Page 
Purified 
MMP-7 from 
mouse 
myeloma 
cells 
(93) 
Activity ↑ Slow 
autoactivation at 
4°C storage 
unknown Purified 
ProMMP in 
SDS-Page 
Purified 
MMP-7 from 
mouse 
myeloma 
cells 
(93) 
Activity ↑ 
 
 
 
 
 
Sulfated GAG 
 
 
 
Promote 
autolytic 
cleavage of 
propeptide 
 
Recombinant 
human 
proMMP-7 
Recombinant 
human 
proMMP-7 
(95) 
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Effectivity ↑ Sulfated GAG 
 
Provide anchor 
and 
compartmentali
ze MMP-7 to 
specific 
substrates 
Recombinant 
human 
proMMP-7 
Recombinant 
human 
proMMP-7 
(95) 
Protein ↑ H.pylori cag+ ERK 1/2 
mediates up-
regulation 
IHC, Western 
Blot 
AGS human 
gastric 
epithelial cells 
(45) 
mRNA ↑ LPS unknown intracellular Peripheral 
human blood 
monocytes 
(75) 
Protein ↑ LPS unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(75) 
Protein ↑ zymosan unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(75) 
mRNA ↑ hypoxia unknown Intracellular/
RT-PCR 
RAW 264.7 
macrophage 
cell line 
(78) 
Protein ↓ Dexamethason 
 
unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(75) 
Protein ↓ 
 
 
All trans retinoic 
acid 
 
unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(75) 
Protein ↓ 
 
 
IL-4 
 
unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(77) 
Protein ↓ IL-10 
 
unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(75) 
Protein ↓ IFNγ 
 
unknown Extracellular/i
mmunoprecip
itation 
Peripheral 
human blood 
monocytes 
(75) 
mRNA ↑ Nitroglycerin  unknown Intracellular/
RT-PCR 
Monocyte 
derived 
macrophages 
(79) 
 
 
In this study, polished and porous titanium disks were analyzed as both surfaces are 
widely used in medical fields. Polished titanium disks are commonly used in dental 
applications (96), whereas porous titanium is applied for femoral and tracheal 
prosthesis (97, 98). Kujala et al. reported promising results for porous titanium with 
respect to osseointegration (99). 
Both polished and porous titanium induced MMP-7 in monocyte-derived 
macrophages. However, a significant expression of MMP-7 in pro-inflammatory M1 
macrophages was observed only on polished titanium, which may be important for 
pathological processes of implant loosening. Regarding MMP-7 and the process of 
implant failure, further studies should be performed in order to evaluate other factors 
participating in the process of implant failure. 
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4.2 The effect of elevated levels of MMP-7 on implant integration 
Elevated levels of MMP-7 may have differential and partially contrary effects on 
extracellular matrix, cells, and cytokines. MMP-7 regulates cell migration or 
contributes to inflammatory processes by activating TNFa, for instance (Table 3, 
Table 7). One of MMP-7 main functions is the degradation of extracellular matrix, 
especially as it has, due to its lack of the hemopexin region, the broadest spectrum 
among all MMPs (Table 3) (21). On the other hand, the activation of TGFb by MMP-7 
may lead to fibrosis (35). The central question is whether the turnover of ECM 
supports osseointegration of titanium implants or if it contributes to the implant failure. 
Shubayev et al. proposed that elevated levels of MMP-7 are essential for the 
implantation of titanium as MMP-7 regulates the turnover of proteoglycans and 
contributes to the solubilization of osteoid. Proteoglycans are crucial for the adhesion 
of titanium implants to bone (91). In contrast, the majority of studies favors the 
hypothesis of MMP-7 contribution to the implant failure (3, 19, 37, 66). Implant failure 
is caused either by excessive ECM degradation and thereby implant loosening or by 
matrix accumulation resulting in fibrosis with a limited function of the implant. Both 
matrix degradation and accumulation has been attributed to MMP-7 (16, 63, 66). 
Matrix degradation by MMP-7 may result in numerous pathologies like aortic 
aneurysm, plaque rupture or aseptic implant loosening (Table 5). Matrix accumulation 
gives rise to fibrosis in different organs. A potential contribution of MMP-7 was found 
in kidney (66), lung (63, 100) or liver (101), for instance. Isao Takei et al. were able to 
demonstrate the expression of MMP-7 mRNA in synovium-like interface tissues 
between bone and prosthesis which was collected from patients with aseptic loose 
artificial hip joints (19). Fibrosis around implants can be detrimental in case it leads to 
capsule contracture, restricting the function of the implant (80). In total knee 
arthroplasty, the pathology of arthrofibrosis has been attributed to the synovial 
membrane and the infrapatellar fat pad. Fibrosis in these structures may prevent a 
normal range of motion and can lead to a dramatic reduction of the quality of life for 
patients (64). However, there is no study which connects elevated MMPs and fibrosis 
around implant material. The experiments in this study have shown an induction of 
MMP-7 by titanium and posed the question whether MMP-7 will contribute either to 
matrix accumulation or degradation. 
In order to answer this question, the paradigm of M1 and M2 macrophages was used 
to distinguish acute inflammatory macrophages as M1 and anti-inflammatory/healing 
macrophages as M2 (61). The paradigm is an effective operationalization to make 
macrophage biology more comprehensible (62). 
Porous and polished titanium induced MMP-7 in M0 and M2 whereas in M1 only an 
induction by polished titanium has been observed, suggesting the induction depends 
on the type of titanium used as well as on the macrophage activation state. 
Macrophage subtypes that have not been exposed to titanium showed no difference 
in MMP-7 expression, suggesting that only titanium induced MMP-7 and not the 
macrophage subtype itself. IL-4 suppresses MMP-7 (96), but titanium supports its 
high expression. 
Differential induction of MMP-7 in M0, M1, and M2 by titanium needs to be 
considered in the context of different roles, macrophage subtypes playing in 
homeostasis and pathologies. In addition, it is of interest if these different expression 
patterns can be observed in connection with pro-fibrotic and matrix degrading 
functions of MMP-7. 
The M1 macrophage subtype is characterized by the production of high levels of pro-
inflammatory cytokines, reactive nitrogen, oxygen intermediates (62), and the ability 
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to kill intracellular pathogens (61). In case of prolonged or extensive activity, they can 
be detrimental to health, sustaining inflammation by the secretion of IL-1-beta, TNFα, 
IL-12, IL-18 and IL-23 (62). Additionally, they are capable of differentiating into 
osteoclasts and thereby contributing to osteolysis (102). By contrast, M2 
macrophages are characterized by their involvement in tissue remodeling, immune 
regulation, tumor promotion, phagocytic activity and parasite control (62). M2 
macrophages have been implicated in fibrosis (103), as they can secrete fibrotic 
factors like TGFβ and Galactin-3 (37). TGFβ promotes collagen synthesis in 
myofibroblasts and can lead to encapsulation of foreign bodies (84, 103), while the 
cellular actions of Galactin-3 lead to cell proliferation, cell adhesion and eventually to 
fibrosis (104). TGFb can also be activated by MMP-7 (35). 
The differential spectrum of function of macrophages, in which M1 macrophages 
contribute to matrix degradation and osteolytic processes, whereas M2 macrophages 
are responsible for fibrosis, suggests different functions of MMP-7 as a function of the 
macrophage subtype expressing it.  
It can be hypothesized that MMP-7, synthesized by M1 macrophages, leads to matrix 
degradation, potentially resulting in aseptic implant loosening and MMP-7 expressed 
by M2 macrophages gives rise to matrix accumulation resulting in fibrosis. M0 
macrophages which are not yet differentiated to M1 or M2 may have the potential to 
cause both implant loosening and fibrosis. A significant up-regulation of MMP-7 by 
M1 macrophages can be observed in samples stimulated with polished titanium 
disks, whereas an up-regulation in M2 macrophages was shown in both polished and 
porous titanium groups. The matrix-degrading or pro-fibrotic function of the enzyme 
can be modulated by other factors which are synthesized by the specific macrophage 
subtype in concert with MMP-7. 
However, considering the absolute levels of the active enzyme (mean concentrations 
under titanium stimulation: M2: 687,3 pg/ml vs. M1: 37,7 pg/ml), MMP-7 secreted by 
M2 macrophages seems to be biological more relevant. Comparison of absolute 
MMP-7 levels with other studies is difficult, as they usually measured serum levels or 
analyzed different cell types. In a study of Abbas et al. mean plasma levels of MMP-7 
were 1960 pg/ml in patients with atherosclerosis, reflecting conditions of chronic 
inflammation. Immunostaining in this study showed that MMP-7 was located next to 
macrophage infiltration (105). 
In the experiments in our laboratory, the concentration of active MMP-7 secreted by 
M2 macrophages stimulated with titanium reached levels above 2000 pg/ml in some 
donors (max. 2916,2 pg/ml) underlining the biological relevance. 
It should be noted that the expression and function of MMP-7 also depends on the 
tissue microenvironment in which multiple factors influence the enzyme. These 
conditions are difficult to simulate in the in vitro experiments. However, the study 
provides relevant data for further analysis in this field. The differences on the 
reactions of macrophages derived from the individual donors suggest the possibility 
to use macrophage-based test system to predict the patient’s individual risk of foreign 
body reaction towards titanium. Patients with a strong induction of MMP-7 can be 
expected to have a higher risk for implant failure. Additionally, the paradigm of M1 
and M2 macrophages allows to discriminate the risk for either aseptic loosening or 
fibrosis. However, more extensive studies in clinical settings from patients both with 
successful and failed implants should be performed in order to identify the correlation 
between MMP-7 production by macrophages and clinical complications in patients 
with titanium implants. 
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ABSTRACT 
Implant material is widely used in medical fields such as orthopedics, odontology or 
cardiology. Due to its excellent properties regarding corrosion resistance and 
biocompatibility, titanium has been used successfully for decades. However, in the 
orthopedic field, studies report failure rates between 3,4-9%. One of the main 
reasons for implant failure is aseptic implant loosening which has been reported to be 
responsible for 80% of revision surgeries. Matrix metalloproteinase and especially 
MMP-7 play a significant role in the pathology of implant failure. MMP-7 has, due to 
the lack of its hemopexin domain, one of the broadest substrate spectrums among all 
MMPs. It can degrade the extracellular matrix as well as activate a large number of 
cytokines. These cytokines, in turn, can cause numerous pathologies (e.g., fibrosis or 
chronic inflammation). Macrophages are the principal cell type involved in the 
orchestration of the foreign body response. In order to analyze the foreign body 
response to titanium, which is one of the most used materials for implants in humans, 
the aim of this work was to examine the effect of human primary macrophage 
exposure to titanium on the MMP-7 production. Using Affymetrix microarray assays it 
was previously identified in our laboratory, that titanium induces MMP-7 gene 
expression in macrophages (82). The specific aims of the current project included 1) 
quantification of titanium induced changes in gene expression and secretion of MMP-
7 in human primary M0, M1 and M2 macrophages; 2) comparative analysis of 
titanium induced MMP-7 production on 3 different levels (mRNA, protein secretion, 
activity); and 3) analysis of TIMP-3 and CD151, regulators of MMP-7 activity, in 
response to titanium stimulation. Analysis of differential effects of porous and 
polished titanium on MMP-7 production by M0, M1, and M2 was performed in the 
model system established in our laboratory where human primary M0, M1, and M2 
macrophages are differentiated out of peripheral blood monocytes cultured on 
titanium disks was used. RT-PCR analysis revealed that both polished and porous 
titanium up-regulate MMP-7 mRNA in M0 and M2 macrophages. Additionally, 
polished titanium was able to induce MMP-7 in M1 macrophages. Protein analysis by 
ELISA confirmed that secretion of MMP-7 correlates with the up-regulated levels of 
mRNA in M0 and M2. Analysis of active MMP-7 demonstrated that titanium induced 
release in M0 and M2 in some donors, however without statistical significance. The 
inducing effect of titanium on MMP7 production was differential on each level of 
regulation with a principal induction on mRNA and protein level. It was shown that 
MMP-7 increased by the time of incubation both under titanium stimulation as well as 
without titanium. The maximum MMP-7 levels were detected on day 6 of incubation. 
Exposure of macrophages to titanium resulted in changes of expression of the MMP-
7 regulators TIMP3 and CD151 in some donors, however without statistical 
significance, suggesting that there are also other mechanisms responsible for the 
post-translational regulation of MMP-7. Collectively, the results demonstrate that 
MMP-7 is statistically significant induced in human primary macrophages by titanium 
on mRNA and protein levels, and in part of donors on the levels of released active 
MMP-7. MMP-7 production was induced in macrophages by both porous and 
polished titanium, while the strongest effect was found in M2 macrophages. As the 
up-regulation of MMP-7 may be essential for the success of the integration of a 
titanium implant, a macrophage-based model system is suggested as a predictive 
tool for implant failure enabling a personalized therapeutic approach.  
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